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Background: Survival of neonates requiring intensive care has improved, but 
many suffer ventilator-related complications. This thesis aims to optimise use 
of ventilation techniques, with a focus on infants born at term.  
Hypotheses: 
   In infants with acute respiratory failure, volume-targeted ventilation (VTV) 
will be superior to pressure-limited ventilation (PLV). 
   Proportional assist ventilation (PAV) will be effective in reducing elastic 
and resistive work of breathing (WOB) in an in vitro experiment.  
Methods: A series of studies were undertaken. 
   National survey of practice in relation to respiratory support in term infants 
   Comparison of WOB at different levels of volume-targeting in term infants 
   Randomised comparison of VTV and PLV in preterm infants  
   Analysis of spontaneous respiratory activity in ventilated term infants 
   In vitro study of effect of elastic and resistive unloading on WOB during 
PAV 
Results: Respiratory support practices for term-born infants differed between 
different levels of care. In term infants, WOB was higher at 4ml/kg compared 
to 5 and 6ml/kg. In preterm infants, there was no difference in time to 
achieve weaning criteria on VTV versus PLV. Fewer infants on VTV 
experienced hypocarbia. Patterns of patient-ventilator interaction were 
described for term-born infants. Active expiration was more common on 
SIMV versus CMV, and less common on triggered ventilation at 4ml/kg 
compared to 6ml/kg or no volume-targeting. Using PAV, elastic unloading 
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1.1 Background  
1.1.1 Historical perspective  
Mechanical ventilation of neonates has been described since the eighteenth 
century. Gorcy, a French physician, developed a bellows-to-tube design of 
ventilator (1), which could provide intermittent positive pressure breaths to 
infant lungs using atmospheric air. In 1828, concerns were raised that 
artificial ventilation caused pneumothoraces (2). In 1829, Magendie and 
Dumeril were commissioned by the French Academy of Sciences to 
investigate the findings of the Parisian surgeon Leroy, who opined that 
distension of the chest with artificial insufflation of air was perhaps harmful in 
comparison to natural respirations (2). The commission published their 
findings (3) confirming that uncontrolled insufflations of air into the trachea 
could cause sudden death, recommending that this technique should only be 
used if applied gently in experienced hands. Following this, interest in 
intermittent positive pressure ventilation waned and did not gain momentum 
again until the twentieth century. For the most part of the twentieth century, 
neonatal ventilators were modified versions of adult ones. An increasing 
understanding of neonatal respiratory insufficiency helped develop 
techniques of neonatal ventilation. In 1953, Donald and Lord published a 
detailed report of their experience of ventilation in ‘atelectasis neonatorum’ 
(4). They described the difficulties faced using a Drinker type of apparatus 
which was a crank-operated bellows-type ventilator which enabled delivery of 
positive pressure ventilation at different rates and pressures. Disappointing 
results using this type of ventilator were attributed to asynchrony leading to 
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ineffective ventilation and hyperventilation resulting in alkalotic tetany. The 
authors attempted to overcome these issues by use of a ‘servo patient-cycled 
respirator’. They described an obvious need for ‘a machine which would 
amplify spontaneous respiratory efforts however irregular’, in what seems an 
almost prophetic foreshadowing of proportional assist ventilation, one of the 
modes investigated in this thesis. This concept was far ahead of its time. The 
combination of severe hyaline membrane disease and intracranial 
haemorrhage resulted in early fatalities (4) and servo-controlled modes of 
neonatal ventilation were not studied again systematically till several decades 
later.  
1.1.2 Epidemiology of ventilated newborns 
Data from 1994 for New York and California, which included 15,006 ventilated 
newborns, demonstrated that 17.8 per thousand livebirths without congenital 
anomalies required mechanical ventilation (5).  In this study, only 36.7% of the 
ventilated infants weighed less than 1500 grams, suggesting that the majority of 
newborns requiring mechanical ventilation were not born extremely prematurely. 
Rates of mechanical ventilation per 1000 livebirths were 502.8 in those born very 
low birthweight (VLBW), 112.9 in low birthweight and 7.2 in normal birthweight 
neonates. 
An epidemiological study from 2008 (6) of 65,000 newborns in France showed 
that the incidence of requirement of mechanical ventilation was also lower in 
infants born at term, but was not insubstantial, being 3.6 per 1000 live born term 
infants (37-41 weeks gestation) without major congenital malformations and/or 
chromosomal abnormalities. Data from New South Wales in Australia (7) showed 
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a rate of mechanical ventilation of 2.6-3.2 per 1000 live born term infants (≥ 37 
weeks gestation) without major congenital anomalies for the years 1992 to 1994, 
an increase on the rate of 1.6 per thousand in 1987. Yet, optimisation of 
ventilation of term born infants has rarely been researched and, therefore, will be 
a major focus of this thesis. 
1.1.3 Underlying respiratory disease 
1.1.3.1 Term born infants 
Of the term infants included in Gouyon’s study (6), 56% had pulmonary pathology 
and the remaining were ventilated for non-respiratory illness. The most common 
respiratory conditions necessitating ventilation were transient tachypnoea of the 
newborn (TTN) (36%), meconium aspiration syndrome (MAS) (31%), respiratory 
distress syndrome (RDS) (19%), pulmonary infection (8%), pneumothorax (3%) 
and persistent pulmonary hypertension of the newborn (PPHN) (2%). Of the 
ventilated newborns with non-respiratory illness, 40% had severe birth asphyxia. 
In Sutton’s study (7) of term newborns in New South Wales, the main indications 
for mechanical ventilation (1992 data) were asphyxia (28.6%), MAS (22.5%), RDS 
(21%), TTN (9.5%), PPHN (5.7%) and infection (4.2%). In contrast, in Clark’s 
study (8) of 1011 ventilated newborns born at a gestation of 34 weeks or above 
the most common respiratory conditions associated with the need for ventilation 
were RDS (43%), MAS (10%), pneumonia/sepsis (8%), TTN (4%), primary PPHN 
(3%) and aspiration of blood or amniotic fluid (2%). The difference in results 
compared to the previous study (6) likely reflects the inclusion of infants who were 
born between 34 and 37 weeks gestation in Clark’s study. Infants born at 34 
weeks have a forty-fold increased risk of RDS than those born at term (9). Non-
respiratory diagnoses leading to the need for mechanical ventilation were major 
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congenital anomalies (17%), severe hypoxic ischaemic encephalopathy (3%) and 
perioperative support (2%) (8).  
1.1.3.2 Prematurely born infants  
Prematurely born infants have lungs that are immature in structure and 
biochemical function, as well as immature respiratory drive. Lung 
development in the fetus occurs in distinct stages – embryonic (3rd to 7th 
week of gestation), pseudoglandular (7th to 16th week of gestation), 
canalicular (16th to 24th week of gestation), saccular (24th week of gestation to 
term) and alveolar (postnatal period to approximately 8 years of age). 
Extremely premature births occur within the late canalicular or early saccular 
phases of lung development. The late canalicular stage is characterised by 
cell differentiation to Type I and II pneumocytes, with gas exchange 
becoming physiologically possible by the end of this phase. Epidemiological 
studies (10, 11) have shown that RDS is the leading respiratory pathology 
affecting prematurely born infants. RDS results from surfactant deficiency.  
Surfactant production in the fetal lung begins during the canalicular stage of 
lung development during 20 to 22 weeks of gestation; sufficient levels are 
reached at about 35 weeks gestation. Even with significant changes in 
practice between the late 1990s and early 2000s, with increased 
administration of antenatal steroids and early administration of exogenous 
surfactant, infants less than 28 weeks gestation with bronchopulmonary 
dysplasia (BPD) in an observational study from the United States were 
shown to have significantly higher duration of mechanical ventilation 




Respiratory disorders are the leading cause of neonatal death in the United 
Kingdom; 37.7% of neonatal deaths in 2008 and 34.4% of neonatal deaths in 
2009 were attributed to respiratory disorders (13, 14). In 2009, of all neonatal 
deaths, severe pulmonary immaturity accounted for 20.2% of deaths, pulmonary 
hypoplasia for 4.1%, surfactant deficiency lung disease for 3.6%, PPHN for 0.9%, 
MAS for 0.8% and BPD for 0.3% (14). Other respiratory disorders accounted for 
the remaining 4.6% of deaths attributable to respiratory causes (14).  It is not clear 
from the CMACE data what proportion of neonates dying of respiratory causes 
received mechanical ventilation.  
Angus reported an overall mortality rate of 11% in ventilated neonates across all 
gestations (5). Gouyon and Clark reported mortality rates of 5% (6) and 6% (8) 
respectively in mechanically ventilated neonates born at term.  
1.1.5 Morbidity 
1.1.5.1 Bronchopulmonary dysplasia  
Bronchopulmonary dysplasia (BPD) was first described by Northway and 
colleagues in 1967 (15). The original description of BPD was that of fibrotic and 
cystic changes in the lung, brought about by mechanical ventilation with high 
pressures and oxygen therapy. In the era of surfactant use and with increasingly 
immature infants being given intensive care, lungs of infants dying from BPD have 
less fibrosis, but deficient alveolarisation (16), leading to the concept that the BPD 
seen nowadays results from arrested lung development (17).  
BPD is now usually diagnosed if an infant is dependent on oxygen and/or positive 
pressure ventilation at the age of 28 days (18). The severity of the BPD is 
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assessed at 36 weeks postmenstrual age (PMA) for infants born at less than 32 
weeks gestation and between 4 to 8 weeks of life in infants born at or more than 
32 weeks (Table 1.1). 
Gestational Age < 32 weeks >32 weeks 
Time of 
assessment 
36w PMA or 
discharge home* 
>28d but <56d postnatal 
age or discharge home* 




Breathing room air at 




Breathing room air at 56 
days postnatal age or 
discharge home* 
 
Moderate BPD Need for <30% 
oxygen at 36w PMA 
or discharge home* 
 
Need for <30% oxygen at 56 
days postnatal age or 
discharge home* 
Severe BPD Need for > 30% 
oxygen with or 
without positive 
pressure ventilation 
or CPAP at 36w PMA 
or discharge home* 
Need for > 30% oxygen with 
or without positive pressure 
ventilation or CPAP at 56 




* Whichever comes first  
Table 1.1 Diagnostic criteria for defining BPD (18).  
Adapted with permission of the American Thoracic Society. Copyright © 2015 




Walsh proposed a physiologic definition of BPD (19) as a more objective measure 
of oxygen dependency in preterm infants. The diagnosis of BPD was determined 
at 36 weeks PMA by applying an oxygen reduction test. Infants receiving a 
fractional inspired oxygen of ≤ 0.3 or > 0.3 with saturations above 96% were 
administered a room-air challenge. Infants maintaining saturations ≥ 90% in room 
air for 30 minutes were classified as not having BPD; if saturations dropped below 
90% during the challenge, a diagnosis of BPD was made. In a multicentre study, 
the incidence of BPD in VLBW infants was reported as 35% using the NICHD 
workshop definition, but only 25% using the oxygen reduction test (19), 
highlighting that  a significant proportion of infants may have been receiving 
supplementary oxygen inappropriately.  
BPD is associated with long-term respiratory morbidity. Differences in lung 
function can be detected from an early age and may persist into late adolescence. 
Northway followed up a group born between 1964 and 1973 and diagnosed with 
the ‘old’ BPD, at a mean age of 18 years, comparing them to matched controls 
who had never been ventilated and age-matched non-premature controls (20). 
The BPD group demonstrated airway obstruction in 68% of subjects, which was 
fixed in a quarter of those affected. The BPD group also had significantly worse 
airflow obstruction and increased gas-trapping.  In an Australian study (21) of 
VLBW survivors from the period 1977 to 1982, studied at a mean age of 19 years, 
22% of the cohort was defined as having the ‘old’ BPD and had significantly worse 
airflow obstruction but not abnormal lung volumes. Rates of asthma were similar 
in the BPD and control groups.  
The evolution of BPD from the ‘old’ to the ‘new’, coinciding with the era of 
surfactant use, has possibly made some difference to long-term respiratory 
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outcomes. One study (22) demonstrated lower FEV1 in the ‘new’ BPD group 
compared to both non-BPD preterm and term controls at 7-8 years of age, a 
finding similar to studies assessing children born in the pre-surfactant era. A much 
larger Australian study (23) assessing children at a mean age of 9 years, 
however, demonstrated that the majority of children in the ‘new’ BPD group had 
lung function within normal range. The difference in FEV1 between BPD and non-
BPD, prematurely born groups was nearly half that found from a similar study in 
the pre-surfactant era (21). Children with BPD have been shown to have higher 
rates of rehospitalisation (24, 25), multiple rehospitalisations (26) and longer stays 
in hospital (27) compared to those without BPD.  
Large studies have indicated that incidence of BPD has not changed significantly 
(28, 29). A nationwide study from the USA (30) however, including data from 9.5 
million VLBW infants between 1993 and 2006, showed an overall 4.3% decrease 
per year in the incidence of BPD in neonates who survived to discharge. Despite 
this reduction in BPD rates, both hospital length of stay and hospital cost of care 
increased significantly for neonates with BPD, with annual increases of 3.9% and 
4.9% respectively, suggesting that the infants surviving with this condition are 
sicker.  
In infants born at term, the rate of long-term oxygen dependency is less, with 
Gouyon reporting rates of 5% (chronic lung disease defined as receiving 
supplemental oxygen at 28 days of life) in infants between 37 and 41 weeks 
gestation who required mechanical ventilation (6) and Clark reporting rates of 
11% (chronic lung disease defined as receiving supplemental oxygen at 30 days 





Pneumothorax is a complication of mechanical ventilation. Greenough et al 
demonstrated that infants displaying a pattern of active expiration against 
ventilator inflations were at higher risk of pneumothoraces (31). With improved 
ventilator technology and the routine use of prophylactic surfactant, the incidence 
of pneumothorax has decreased. A systematic review (32) has shown that 
prophylactic surfactant compared to selective surfactant was associated with a 
significantly reduced risk of pneumothorax (RR 0.62, 95% CI 0.42, 0.89) as well 
as pulmonary interstitial emphysema (RR 0.54, 95% CI 0.36, 0.82). The 
introduction of patient-triggered, synchronised modes of ventilation was not 
accompanied by a demonstrable reduction in pneumothorax. A systematic review 
comparing triggered modes to CMV did not show any impact of triggered modes 
on the incidence of air leaks in neonates (33). Volume-targeted ventilation in 
prematurely born infants has been shown to be associated with a lower incidence 
of pneumothorax in a systematic review (RR 0.46, 95% CI 0.25, 0.84) (34). 
Pneumothoraces are not only a problem in prematurely born infants. In Gouyon’s 
study, 24% of term infants ventilated for severe respiratory disorders developed 
pneumothoraces (6). Therefore, it is important to investigate ventilatory strategies 
which might reduce their incidence. In a randomised study comparing pressure-
limited to volume-targeted ventilation, the hypothesis that volume-targeted 
ventilation would be associated with a reduction in the incidence of pneumothorax 
will be investigated.   
1.1.5.3 Neurological complications 
Ventilation strategy can influence neurological outcomes in the sick neonate 
primarily by the relationship of cerebral blood flow to the partial pressure of arterial 
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carbon dioxide (PaCO2). Hypocarbia causes cerebral vasoconstriction and 
hypercarbia causes cerebral vasodilation. Wide and sudden fluctuations in PaCO2 
are thus undesirable. Hypocarbia is associated with increased risk of 
periventricular leukomalacia (PVL) and severe intraventricular haemorrhage (IVH) 
in prematurely born infants (35-37). In term infants with hypoxic ischaemic 
encephalopathy, hypocarbia was found to be associated with an increased risk of 
death or disability at 18 to 22 months (38). Prolonged hypocarbia is also 
associated with hearing loss in term and near-term infants (39). In a randomised 
study, the hypothesis that volume-targeted ventilation compared to pressure 
limited ventilation will reduce the incidence of hypocarbia will be tested.  
1.2 Ventilator-induced lung injury / Ventilator-associated lung injury 
As early as 1745 there was a report suggesting that mechanical inflation of human 
lungs may be injurious (40). This concept has now been extensively investigated 
and damage caused by artificial ventilation may be broadly grouped into four 
categories: barotrauma, volutrauma, atelectrauma and biotrauma (41). Lesions 
produced by mechanical ventilation in laboratory animal experiments have been 
termed ‘ventilator-induced lung injury’ (VILI) and the counterpart seen in humans 
in clinical practice is called ‘ventilator-associated lung injury’ (VALI). 
1.2.1 Barotrauma 
Gross anatomical damage caused to the lung by high positive pressures has been 
historically described as barotrauma. It is classically manifest as extra-alveolar air 
leaks such as pulmonary interstitial emphysema, pneumothorax and 
pneumomediastinum. Macklin’s study (42) demonstrated how an increased 
pressure gradient between the alveoli and vascular sheath led to entrance of air 
30 
 
into the interstitium. At  the same time that Northway (15) described  BPD in 
premature infants with RDS, Barnes and colleagues (43) published a report 
describing the radiological appearances, airways resistance, static and dynamic 
lung compliances, and histological characteristics of the lungs of six infants 
receiving prolonged positive pressure ventilation with high airway pressures. 
Those infants had been ventilated for respiratory insufficiency secondary to RDS, 
cardiac disease or pneumonia and ranged from one day to 13 weeks in age. High 
pressures had been used during ventilation, with mean peak inflation pressures 
starting off around 20-30 cm H2O, but rising to 35-45 cm H2O and at times up to 
60-70 cm H2O. The authors noted that the characteristics of the lungs in the group 
of infants closely resembled the chronic phase of BPD as described by Northway, 
yet only two of the six infants described had RDS or were ventilated with high 
oxygen concentrations. It was concluded that the lung damage might be attributed 
to the high pressures used during ventilation.  
1.2.2 Volutrauma 
In 1992, Dreyfuss and Saumon declared, “Barotrauma is volutrauma” (44). They 
put forward the case that it was actually high tidal volumes generated during 
positive pressure ventilation that caused lung damage. Animal studies have 
shown that increases in airway pressure without a corresponding increase in lung 
volume (achieved by restricting chest and abdominal wall movement by binding) 
did not produce the lung injuries seen in high peak pressure ventilation with no 
restriction of volume change (45-47). Injuries attributed to lung overinflation 
include increases in alveolar-capillary permeability, pulmonary oedema and 
ultrastructural damage such as discontinuities in alveolar type I cells (48), 
endothelial cell detachment exposing the basement membrane and endothelial 
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cell breakage (49). In lungs acutely injured prior to ventilation, overinflation was 
shown to cause more severely increased permeability and oedema than in normal 
lungs (50, 51). This suggests that infants ventilated for severe respiratory 
disorders may be more susceptible to volutrauma. The ARDS Network trial was 
stopped early when the interim analysis revealed a 22% reduction in mortality 
when adult ARDS patients were ventilated with 6ml/kg compared to 12ml/kg (52). 
This thesis will examine the impact of different levels of tidal volume targeting on 
the physiological outcome of work of breathing in infants born at term.  
1.2.3 Atelectrauma 
Suboptimal inflation of the lungs can also be damaging, and the effect of repetitive 
opening and collapse of distal airways has been termed atelectrauma. Robertson 
et al suggested that the force required to open up atelectatic areas in lungs 
affected with RDS may cause shear stress leading to epithelial disruption (53). 
Other mechanisms have been suggested as contributing to lung injury during low 
volume ventilation: decreased partial pressure of oxygen in atelectatic alveoli can 
cause cell damage and atelectasis can inhibit surfactant production and cause 
uneven distribution of surfactant. Another hypothesis put forward is that of 
increased regional stress during re-expansion of atelectatic areas situated 
adjacent to areas of normal expansion. Positive end-expiratory pressure (PEEP) 
has been shown to be protective against atelectrauma. Determining optimal lung 
recruitment manoeuvres and tidal volume targets would help in prevention as well. 
The deleterious effect of using tidal volumes that are too low has been highlighted 
in studies of preterm ventilation (54, 55). In this thesis, the effect of different levels 
of volume targeting will be assessed to determine the optimal volume to be used 




The mechanical factors that lead to barotrauma, volutrauma and atelectrauma 
have been associated with inflammatory mediator-related injury which has been 
termed biotrauma.  
Pugin showed that human alveolar macrophage preparations subjected to cyclic 
stretch stimuli mimicking high tidal volume ventilation released interleukin 8 (IL-8),  
a chemokine that attracts neutrophils (56). Similar findings were reported by 
Vlahakis in human alveolar epithelial cells (57). This may explain the mechanism 
of neutrophil infiltration in VILI. In a series of experiments on isolated, unperfused 
rat lungs (58), all traumatic ventilation strategies [moderate volume (15ml/Kg), 
zero PEEP; high volume (40ml/Kg), zero PEEP] were associated with increased 
inflammatory cytokine levels in bronchoalveolar lavage (BAL) fluid.  
Belperio showed that knockout mice for the MIP-2 receptor showed less VILI than 
wild-type mice when subjected to high tidal volume ventilation, suggesting an 
important role for IL-8 (human equivalent) in the pathogenesis of VALI (59).   
Ranieri showed reduction in BAL and plasma concentrations of cytokines 
associated with lung-protective ventilation strategies (60). In a study of 30 preterm 
neonates with RDS randomised to receive volume guarantee (VG) ventilation at 
either 3ml/kg or 5ml/kg, Lista et al showed that the lower level was associated 
with a significantly higher level of BAL IL-8 on Day 7 (p<0.05) as well as a shorter 
duration of ventilation (p=0.05) (55).  
1.2.5 Asynchrony 
Asynchrony between the patient and ventilator is a mismatch between the 




Asynchronous ventilation adversely affects oxygenation and gas exchange in 
neonates and can lead to the need for higher airway pressures to achieve 
adequate gas exchange (61). Asynchrony increases the risk of air leaks (62). 
Asynchrony is associated with an increased work of breathing (63) and an 
increased duration of ventilation due to ineffective weaning (64). This thesis 
will examine patterns of interaction between ventilated term born infants’ 
respiratory efforts and mechanical inflations and determine if there is any 
association between asynchronous interactions and modes of ventilation or 
volume target levels.  
1.2.6 Ventilator-induced diaphragmatic dysfunction (VIDD) 
Ventilator-induced diaphragmatic dysfunction is characterised by a decrease 
in the force-generating capacity of the diaphragm in a time-dependent 
manner in ventilated subjects and is related to disuse atrophy (65). It is 
mainly a complication of controlled ventilation modes and has been shown to 
be attenuated with assisted ventilation modes (66, 67). It has been 
demonstrated in animal studies (68, 69). Evidence is emerging that it occurs 
in humans (70, 71). Postmortem analysis revealed diffuse diaphragmatic 
muscle fibre atrophy in human neonates who were mechanically ventilated 
for 12 days or more immediately before death; those changes were not 
present in diaphragms of infants ventilated for seven days or less (72). VIDD 
could explain the difficulties encountered in weaning and discontinuation of 
mechanical ventilation in some patients.  Hence it is important to carry out 
studies where clinical outcomes may be related to physiological measures of 
respiratory muscle function, to determine if diaphragmatic dysfunction is 
clinically important in ventilated neonates. In this thesis, volume-targeted 
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ventilation will be compared to pressure-limited ventilation to determine which 
mode is associated with superior respiratory muscle strength.   
To protect the infant from VALI, VIDD and BPD, optimising ventilation so that 
rapid weaning and extubation can be facilitated is important. In this thesis, 
outcomes will include time to achieve specified weaning criteria and 
physiological measures quantifying WOB and respiratory muscle strength, to 
compare the efficacy of volume-targeted and pressure-limited ventilation. 
1.3 Modes of ventilation 
1.3.1 Conventional modes 
1.3.1.1 Continuous Mandatory Ventilation (CMV) 
Until the early 1970s, newborns were ventilated with modified adult ventilators. 
The earliest form of mandatory ventilation, intermittent positive pressure 
ventilation (IPPV) was delivered by these devices using intermittent gas flow. 
Spontaneous infant breaths were thought undesirable as the baby would 
rebreathe ‘dead air’ (73, 74). Clinicians concentrated on abolishing infant 
respiratory efforts with pharmacological paralysis or hyperventilation. The next 
generation of ventilators incorporated design features which provided a 
continuous flow of fresh gas allowing spontaneous breathing during mechanical 
ventilation (75). The provision of mechanical breaths at a fixed rate while allowing 
simultaneous spontaneous infant breathing was termed intermittent mandatory 
ventilation (IMV) (76). Non-synchronised IMV with a view to providing full 
ventilator support to the infant is commonly termed continuous mandatory 
ventilation (CMV) (77). 
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During CMV, the ventilator delivers the set peak inspiratory (PIP), inspiratory time 
and rate regardless of infant respiratory effort. Those characteristics mean that 
CMV may be associated with asynchronous patient-ventilator interactions. 
Asynchrony is associated with adverse effects such as impaired gas exchange, 
increased risk of air leak (62) and increased risk of IVH (78, 79). Greenough 
described the different patterns of patient ventilator interaction in ventilated 
preterm infants on CMV: active expiration against ventilator inflation was the 
second most common interaction and was associated with pneumothorax and 
poor blood gases (31). 
1.3.1.2 Patient-triggered ventilation 
By the 1990s, ventilator technology was sufficiently advanced to enable patient-
triggered modes to be used in neonates. Various methods have been used to 
sense the patient inspiratory effort which triggers the delivery of a ventilator 
breath. Currently, flow-sensing pneumotachographs are widely used to deliver 
patient-triggered modes. Synchronised Intermittent Mandatory Ventilation (SIMV) 
and Assist/Control Ventilation (ACV) have been used most commonly in 
neonates. In SIMV, ventilator inflations at the rate set by the clinician are 
synchronised to the onset of spontaneous infant breaths. The infant is able to 
breathe spontaneously between ventilator inflations, but breaths above the preset 
ventilator rate are not supported. In ACV, every spontaneous infant inspiratory 
effort that exceeds the trigger threshold is supported by a mechanical inflation.  
Triggered ventilation should, in theory, reduce asynchronous patient-ventilator 
interactions. Animal studies have shown preservation of diaphragm function using 
triggered modes compared to CMV (66, 67). A systematic review of patient-
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triggered modes in newborns (33) showed that ACV/SIMV was associated with a 
shorter duration of ventilation compared to CMV (weighted mean difference -34.8 
hours, 95% CI -62.1, -7.4). ACV was associated with a trend to a shorter duration 
of weaning compared to SIMV (weighted mean difference -42.4 hours, 95% CI -
94.4, 9.6). Triggered ventilation was not associated with a significant reduction in 
the incidence of BPD. 
  
1.3.2 Newer ventilation modes 
1.3.2.1 Volume-targeted ventilation (VTV) 
Volume-controlled ventilators have been in use for adults since the 1960s. In 
1971, Kirby described a design for a new volume ventilator specifically targeted 
for neonatal and paediatric use accompanied by case reports describing its 
successful use in four infants (80). Despite the theoretical advantages of volume-
targeted ventilation, it did not become prevalent in neonatal clinical practice or 
feature as the subject of further clinical studies in neonates until more than two 
decades later. This was because ventilator technology in the 1970s and 1980s 
was limited by various factors, including inability to measure the very small tidal 
volumes that characterise neonatal ventilation, compliant ventilator circuits which 
exacerbated loss of volume, and suboptimal trigger response times. In addition, 
the use of uncuffed endotracheal (ET) tubes in neonates means there is a 
variable leak around the ET tube, which affects the volume of gas actually 
delivered to the lungs. A new generation of ventilators driven by microprocessor 
technology and fitted with modern flow sensors, enabling tidal volume 
measurement near the infant’s airway and provision of leak compensation, 
37 
 
introduced the prospect of volume-targeted ventilation (VTV) in even extremely 
low birth weight neonates.  
VTV is designed to deliver a consistent tidal volume with every inflation 
despite changing lung mechanics. This is accomplished by the 
microprocessor-based technology of modern ventilators which allows delivery 
of the mode according to algorithms written into software. During volume-
targeted ventilation a set tidal volume is delivered within the limits of the 
maximum allowed PIP set by the clinician. Expiratory tidal volume is most 
commonly monitored and targeted as it is less affected by leak around the ET 
tube compared to inspiratory tidal volume. Volume-targeting can be used in 
conjunction with CMV, SIMV, ACV or pressure support.  
VTV can be considered an ‘umbrella’ term encompassing a range of modes 
(Table 1.2). An in vitro lung model study (81) testing four different ventilators 
(Dräger Babylog 8000-plus, SLE 5000, Stephanie and VIP Bird Gold) 
showed that with the same settings in volume-targeted mode, the Stephanie 
and VIP Bird delivered significantly lower MAP and PIP and the SLE 5000 
and VIP Bird delivered significantly shorter inflation times. These differences 
in performance could be related to the different pressure waveform produced 
by each ventilator. This thesis will investigate VTV delivered by the SLE 5000 













Clinician selects target VT and 
maximum PIP. The ventilator 
uses the expiratory VT of the 
previous breath to determine 
gradual adjustment of PIP to 
reach the target VT over the 
next few breaths.  
Targeted Tidal 
Volume plus  
 
(TTVplus) 
SLE 5000 Clinician sets target VT and 
maximum PIP. The ventilator 
makes use of a ‘test breath’ 
every few breaths to make 
gradual adjustments of PIP to 
achieve the target VT.  
Volume-limited 
Ventilation 
Stephanie Clinician sets a maximum VT 
‘limit’. If expiratory VT reaches 
this limit, PIP of the subsequent 








Clinician selects target VT and 
maximum PIP. An initial breath 
with PIP 10 cm of H2O above 
PEEP is used as a reference to 
calculate PIP required to deliver 
set VT according to lung 
compliance. Automatic 
adjustments of PIP occur in 
steps of 3 cmH2O to maintain 
set VT.  
Volume-Assured 
Pressure Support  
 
(VAPS) 
VIP Bird Gold Clinician selects the target Vt. 
Breaths start off as pressure-
support. Delivered VT is 
measured when inspiratory flow 
decelerates to the set minimum 
– if it exceeds the set VT the 
breath is terminated by flow-
cycling, if it is less then 
inspiratory flow continues till set 
VT is achieved.  
Volume-Support 
Ventilation  
Servo-i Clinician selects target VT, 
minute volume and rate. Patient 
determines the inspiratory time. 
Automatic adjustment of PIP in 
consecutive breaths until target 
VT is reached.  
Pressure 
Augmentation 
Bear 1000 Clinician selects minimum VT, 
ventilator adjusts flow to deliver 
this; PIP remains fixed.  
Table 1.2 Volume-targeted ventilation modes 
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VTV would appear to hold great benefits: by providing a uniform tidal volume 
it would offer protection from volutrauma and atelectrauma. Autoweaning of 
PIP that is incorporated in this mode would prevent hypocarbia. A recent 
survey highlighted that VTV was routinely used in 60% of neonatal units in 
Australasia and 40% of units in Sweden, Denmark, Finland and Norway (82).  
The most common reason given for using VTV was that it reduces BPD. 
Systematic review of the results of twelve randomised controlled trials 
(RCTs), however, demonstrated that whereas use of VTV was associated 
with a significant reduction in pneumothoraces, grade 3-4 intraventricular 
haemorrhage/periventricular leukomalacia and the combined outcome of 
death or BPD, the reduction in BPD defined as oxygen dependency at 36 
weeks postmenstrual age was of borderline significance, and there was no 
significant effect on BPD defined as oxygen dependency at 28 days (34).  
The RCTs included only prematurely born infants. It is not known whether 
VTV is being used in term infants despite the lack of evidence to support its 
use in this group. As part of this thesis, a national survey of ventilation 
practice relating to term born infants will be carried out.  
Klingenberg’s survey (82) highlighted considerable variation in VTV practice 
in that the median (range) of upper limits of target tidal volume were 5 (4-8) 
ml/kg for the initial ventilation of prematurely born infants and 6 (4-10) ml/kg 
for infants with ventilator-dependent BPD. Yet, the level of volume targeting 
influences the infant’s work of breathing. In both acute respiratory distress 
(83) and during weaning (84), it has been demonstrated that use of 6 ml/kg 
compared to 4 ml/kg was associated with a significantly lower 
transdiaphragmatic pressure time product (PTPdi), which is a measure of the 
40 
 
work of breathing (WOB). Polimeni’s study in preterm infants (54) showed 
that SIMV with a volume-target of 6ml/kg rather than 4.5ml/kg was 
associated with significantly reduced duration of hypoxaemic episodes 
compared to SIMV with no volume-target. Lista compared the effect of 
volume-targeting at 3ml/kg vs 5ml/kg in preterm infants (55). The 5ml/kg 
group had a shorter duraton of ventilation, just reaching statistical 
significance. The study analysed the level of pro-inflammatory cytokines in 
tracheal aspirate and found a significantly higher level of IL-8, a cytokine 
associated in the pathogenesis of BPD, on day 7 of the group ventilated with 
3ml/kg. Those results suggest a role for the higher tidal volume in attenuating 
an inflammatory response in the acute stage of respiratory disease. These 
studies from Patel, Polimeni and Lista (54, 55, 83, 84) underline the fact that 
determining the optimal tidal volume to target is necessary before 
determining a protocol for comparing VTV to PLV in a randomised study. 
This thesis aims to determine the optimal level of tidal volume targeting in 
infants born at term with regard to the outcome of WOB. In a subsequent 
study, volume-targeted ventilation will then be compared to pressure-limited 
ventilation with assessment of short-term clinical and physiological outcomes.  
1.3.2.2 Proportional Assist Ventilation (PAV) 
 In PAV, the clinician can set levels of elastic and resistive unloading to be 
delivered by the ventilator. The patient’s spontaneous respiratory effort 
determines the triggering, amplitude and termination of mechanical breaths, 
which the ventilator provides by servo-control (85). Thus, theoretically, there 
could be perfect synchronisation of patient and ventilator. For neonates, a 
backup mode must be provided in conjunction with PAV to support periods of 
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inadequate respiratory effort (86). The aim of PAV is to match the ventilator 
to the infant’s respiratory efforts so that the work of breathing of the infant is 
reduced. Thus in theory, it is possible to produce an inflation pressure wave 
which is in phase with the inspiratory volume of the infant in situations where 
the main mechanical problem is one of low lung compliance e.g. the 
respiratory distress syndrome, a technique known as elastic unloading, 
elastance being the reciprocal of compliance. Inflation pressure can also be 
produced in phase with the infant’s inspiratory flow when resistance is high 
(resistive unloading).The infant controls the onset and termination of 
inspiration. The operator is helped in this as the ventilator displays both the 
compliance and the resistance of the respiratory system.   
Proportional assist ventilation (PAV) was first recommended as an alternative 
and potentially less damaging form of respiratory support for neonates in 
1998 (87) but has been slow to be adopted and not yet subjected to large 
randomised clinical trials. In acute respiratory disease in prematurely born 
infants, PAV was associated with maintenance of gas exchange with lower 
transpulmonary pressure swings compared to CMV and ACV in a crossover 
study (88). In evolving chronic lung disease in prematurely born infants, PAV 
was shown to provide satisfactory gas exchange at lower mean airway 
pressures compared to SIMV and ACV in a crossover study (86). PAV has 
also been demonstrated to reduce thoraco-abdominal asynchrony and chest 
wall distortion in preterm infants (89).  
One of the reasons PAV has not been assessed in larger studies is that 
optimal settings have yet to be identified. Schulze (87) showed that high 
levels of unloading lead to runaway inspiratory pressure oscillations, 
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particularly when the resistance is low. In addition, a recent in vitro study (90) 
using a dynamic lung model found that although progressive unloading led to 
largely matched increases in airway opening pressures and reductions in 
“pleural” pressures, there was a delay in the onset of inflation and occurrence 
of oscillations in the pressure waveform at certain levels of unloading 
depending on the characteristics of the lung model. It also remains unclear of 
the extent to which the runaway pressure oscillations might affect the infant’s 
WOB. In this thesis, the effect of PAV on elastic and resistive WOB will be 
assessed in vitro.  
1.4 Outcome measures 
1.4.1. Physiological measurements 
1.4.1.1 Work of breathing 
The anatomy and physiology of newborns predisposes them to an increased 
work of breathing. Their predominantly cartilaginous ribcage is highly 
compliant; this effect is more pronounced with decreasing gestational 
maturity. They spend a large proportion of time in rapid eye movement sleep; 
the consequent inhibition of intercostal muscle tone further destabilises the 
thoracic cage. A significant amount of the force generated by diaphragmatic 
contraction is thus lost in distortion of the ribcage as opposed to production of 
inspiratory flow.  
The resistance of a muscle to fatigue correlates with its proportion of high-
oxidative muscle fibres. In prematurely born neonates, the diaphragm contains 
only 10% type I (slow-twitch, high-oxidative) fibres, in term infants the proportion 
of type I fibres is 25% and in children over 2 years of age it is 55% (91). Thus the 
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diaphragm of the newborn, particularly if premature, is more susceptible to 
fatigue. Total abolition of WOB in ventilated infants is undesirable. Inactive 
muscles rapidly lose oxidative capacity (92) and thus become more prone to 
fatigue. In an adult human study, marked atrophy of diaphragm myofibrils was 
demonstrated with as little as 18 hours of diaphragmatic inactivity (70). Excessive 
WOB in ventilated neonates has adverse consequences. Increased metabolic 
requirements from high WOB increase susceptibility to fatigue (93): this has the 
effect of the infant requiring more support from the ventilator, thus prolonging 
weaning (94). The caloric requirements of increased WOB may adversely impact 
on infant growth at a critical stage in their development. Infants with a high WOB 
are more likely to fail extubation (95). Previous studies (83, 84) have shown that in 
preterm infants, volume-targeting at 6ml/kg compared to 4ml/kg was associated 
with a significantly lower WOB.  This thesis aims to determine the optimal level of 
volume targeting in term infants with regard to the outcome of WOB. Once the 
optimal volume-targeting level has been determined, this thesis will test the 
hypothesis that VTV will be associated with a significantly lower WOB compared 
to PLV. 
1.4.1.2 Respiratory muscle strength 
The strength of the respiratory musculature is represented by its contractile 
force, which is directly proportional to spontaneously generated airway 
pressures. In neonates, assessment of respiratory muscle strength can be 
made by recording the maximal negative and positive pressures generated 
during crying against airway occlusion at functional residual volume and total 
lung capacity respectively (96). These measurements are termed Pimax and 
Pemax, as they represent the maximal inspiratory and expiratory pressures 
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respectively the subject is able to generate. This thesis aims to investigate 
whether respiratory muscle strength is superior with volume-targeted 
ventilation compared to pressure-limited ventilation.  
1.4.2. Duration of ventilation  
While mechanical ventilation is essential in management of neonatal 
respiratory failure, it is desirable to wean the infant from the ventilator as 
soon as possible so as to avoid risks associated with VILI/VALI. For the RCT 
comparing volume-targeted to pressure-limited ventilation in prematurely 
born infants, the time to achieve pre-specified weaning criteria has been 
chosen as the main outcome measure.  
1.4.3 Hypocarbia 
Hypocarbia is an abnormally low partial pressure of carbon dioxide within 
arterial blood. Mechanically ventilated infants are at risk of developing 
hypocarbia. Carbon dioxide regulates cerebral blood flow in neonates (97), 
and both preterm and term neonates show a reduction in cerebral perfusion 
in response to hypocarbia (98). Erickson’s study (35) reported significantly 
increased risk of severe IVH or PVL if hypocarbic (pCO2 < 4 kPa) in the first 
48 hours of life and of BPD if hypocarbic on at least three occasions in the 
first 24 hours of life. In the 2010 Cochrane review of volume-targeted versus 
pressure-limited ventilation in prematurely born neonates (34), hypocarbia 
was a secondary outcome measure analysed and was defined as pCO2 less 
than 4.7 kPa. In the randomised study comparing volume-targeted to 
pressure-limited ventilation in preterm neonates carried out as part of this 
thesis, hypocarbia in the first 72 hours of life is reported as a secondary 
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outcome and is defined as a value of pCO2 of less than 4.5 kPa on any blood 
gas.  
1.5 Patient-ventilator interactions  
In most circumstances, some degree of respiratory effort is retained by a 
mechanically ventilated infant. In ventilated neonates, interactions with the 
ventilator may be produced by the elicitation of respiratory reflexes by the delivery 
of a mechanical breath. These interactions were described in detail by Greenough 
et al in ventilated prematurely born infants (31) and can be classified into four 
distinct patterns as follows: 
- Inspiration coinciding with ventilator inflation (synchrony) 
- Active expiration against ventilator inflation  
- Prolongation of spontaneous expiration during ventilator inflation 
- Deep inspiration coinciding with ventilator inflation (augmented 
inspiration) 
1.5.1 Synchrony 
In this pattern the infant’s spontaneous breath coincides with the mechanical 
breath. No respiratory reflexes are involved.  
1.5.2 Active expiration 
Here, the infant actively expires against the ventilator breath. This may be 
brought about by the stimulation of the Hering-Breuer expiratory reflex in the 
infant by the mechanical positive pressure breath stimulating pulmonary 
slowly adapting stretch receptors. The Hering-Breuer expiratory reflex was 
described in 1868 – prolonged inflation of the lungs of anaesthetised animals 
elicited an active expiratory effort (99). 
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1.5.3 Prolongation of expiration 
In this pattern, passive expiration continues for longer than expected 
because of a decrease in spontaneous inspirations. This pattern of patient-
ventilator interaction is thought to be produced by elicitation of the Hering-
Breuer inflation reflex in the infant by the mechanical breath. In the Hering-
Breuer inflation reflex, distension of the lungs in mechanically ventilated 
animals led to a decrease in the frequency of inspiration (99). This reflex has 
been shown to occur in human neonates (100). 
1.5.4 Augmented inspiration 
These exaggerated inspirations coinciding with a mechanical breath are 
thought to be due to provocation of Head’s paradoxical reflex. This reflex was 
first described by Head (101) as a prolonged, forceful contraction of the 
diaphragm during rapid lung inflation on a background of vagal blockade. In 
neonates it is likely produced by stimulation of vagally-innervated irritant 
receptors within the large airways.   
It is not known whether term infants display similar interactions influenced by 
respiratory reflexes. Delineating how term born infants interact with mechanically 
delivered breaths may help in optimisation of ventilation in this group. This thesis 
will attempt to identify and analyse patterns of patient-ventilator interaction in term 
born infants.  
1.6 Hypothesis  
The majority of studies assessing neonatal ventilation have been carried out on 
prematurely born infants. This thesis will focus on optimisation of ventilation in 
term born infants. The hypotheses to be tested are: 
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 There will be significant differences in ventilation practice relating to 
infants born at term 
 Higher levels of volume-targeting will be associated with lower work of 
breathing in infants born at or near term 
 In prematurely born infants with acute respiratory failure, volume-targeted 
ventilation will be superior to pressure-limited ventilation 
 Infants born at term will display interactions with ventilator inflations 
similar to prematurely born infants 
 Elastic and resistive unloading with PAV will be equally effective in 
reducing the work of breathing of a lung model. 
1.7 Aims 
 To carry out a national survey of ventilation practice in infants born at term. 
 In infants born at or near term, determination of the optimal tidal volume target 
which will be associated with the lowest work of breathing as reflected by 
PTPdi.   
 Randomised comparison of volume-targeted and pressure-limited ventilation in 
prematurely born infants, assessing outcomes of time to achieve weaning 
criteria, work of breathing and respiratory muscle strength. 
 Analysis of patient-ventilator interactions in term born infants to determine if 
there is any difference in interactions on mandatory versus triggered ventilation 
or related to differences in volume-targeting.  











































 National survey examining clinical practice in relation to respiratory 
support in term infants 
 
 Comparison of different levels of tidal volume targeting in term infants 
 Randomised comparison of volume-targeted and pressure-limited 
ventilation in preterm infants  
 Description of spontaneous respiratory activity in ventilated term infants 
and comparison of patient-ventilator interactions 
 In vitro study analysing effects of proportional assist ventilation (PAV) 
on the work of breathing  
2.2 Ethics 
The clinical studies were approved by the King’s College Hospital Research 
Ethics committee. Infants were recruited from the neonatal intensive care unit 
at King’s College Hospital, London. Written, informed consent was obtained 
from the infant’s parent(s).  
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2.3 Clinical studies 
2.3.1 Equipment 
2.3.1.1 Measurement of flow and airway pressure 
A pneumotachograph (Mercury F10L, GM Instruments, Kilwinning, Scotland) 
was used to measure flow of gas. It was inserted between the endotracheal 
tube and ventilator Y-piece (Figure 2.1) and connected to a differential 
pressure transducer (MP45, range ± 2 cm H2O, Validyne, Northridge, CA, 
USA). Airway pressure was measured via tubing from the side port of the 
pneumotachograph connected to another differential pressure transducer 
(MP45, range ± 100 cm H2O Validyne Corp, Northridge CA, USA). The 
signals from the pressure transducers were amplified using a carrier amplifier 
(CD 280, Validyne, Northridge, CA, USA).  
 
Figure 2.1 Pneumotachograph inserted between endotracheal tube and 












2.3.1.2 Measurement of oesophageal and gastric pressures  
Measurement of oesophageal (Poes) and gastric pressures (Pgas) was carried out 
using a flexible, silicone-coated catheter (7 French gauge) and fitted with two 
microtransducers five centimetres apart (Model CTO-2; Gaeltec Ltd, Dunvegan, 
Scotland, UK) (Figure 2.2).  Each sensor consisted of a metal diaphragm with 
directly deposited resistive strain gauges. The silicone coating on the sensing 
area allowed a small amount of water absorption which could cause a baseline 
drift hence the catheter was soaked for a total of two hours prior to use to allow 
stabilisation of the baseline. The distal transducer (gastric) was located three mm 
from the catheter tip. The length of insertion of the catheter was estimated using 
the method for insertion of an orogastric or nasogastric tube (102). The catheter 
tip was lubricated with a small amount of sterile aqueous gel (Aquagel, Williams 
Medical Supplies, Gwent, Wales, UK). The aim was to position the distal 
transducer in the stomach and the proximal transducer in the lower third of the 
oesophagus. Correct placement of the catheter was confirmed by checking that 
there was good agreement between oesophageal and airway pressure changes 
during an airway occlusion, with the Poes/Pao ratio between 0.9 and 1.10 (103). 
Signals from the catheter were amplified via a dedicated transducer control unit 




Figure 2.2 Tip of catheter used for oesophageal and gastric pressure 
measurements 
2.3.1.3 Calibration  
 
Calibration of airway pressure, flow, and dual microtransducers were carried 
out prior to each measurement. A two point calibration of pressure 
transducers was performed using a portable pressure meter (Comark, 
Welwyn Garden city, UK).  The linearity of the Comark pressure meter was 
tested against a water manometer (Figure 2.3).  Flow was calibrated using a 
low flow rotameter (0-12 L/min Platon, Roxspur Measurement & Control Ltd, 











Figure 2.3 Linearity of Comark pressure meter tested against a water column 
 
2.3.2 Linearity of systems 
Linearity of each system used to measure oesophageal, gastric and airway 
pressure was tested by plotting pressure input to the individual transducer via the 
Comark pressure meter against the digitised output displayed by the software 
programme. Linearity was demonstrated for oesophageal and gastric pressure 
measurement between -50 to 50 cm H2O pressure and for airway pressure 













Figure 2.6 Linearity of airway pressure transducer 
 
Linearity of the system used to measure flow of gas was tested by plotting flow 
input via the rotameter to the pressure transducer against the digitised output 
displayed by the software programme. The system was tested for four different 





Figure 2.7 Linearity of flow measurement 
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2.3.3 Frequency response 
The signal frequency range of an airway, oesophageal or gastric pressure 
wave response is determined by the respiratory rate, which for a neonate 
may fall between the range of 60 to 120 breaths per minute. Therefore the 
fundamental frequency (the first harmonic) is 1-2 Hz. The first ten harmonics 
contribute to the pressure waveform. Ideally the frequency response of the 
measuring system should be at least ten times the frequency of the infant’s 
respiratory efforts, i.e. 20 Hz, to enable it to reproduce the first ten harmonics 
of the pressure wave without distortion. 
Frequency response can be determined by a ‘pop test’ (104) in which an 
inflated balloon is fitted over the signal input site and then burst, producing an 
instantaneous negative step input to the system. The frequency response of 
the system (f3db) is calculated using the equation f3db =1/3 x Tr, where Tr 
(response time) is defined as the time taken for pressure to fall from 90% to 
10% of the initial pressure. 
The frequency response of each system used  was determined using the pop 
test method, with the change in pressure against time recorded on a 
computer (MacBook, Apple Computer Corp, Cupertino, California, USA) 
using Chart software (Version 5.0, ADInstruments Pty Ltd, Bella Vista, NSW 
Australia) with analogue-to-digital sampling at 40KHz (Powerlab, 
ADInstruments Pty Ltd, Bella Vista, NSW, Australia). 
The frequency response of the airway pressure transducing system 
(consisting of the pressure transducer, connecting tubing, amplifier and 
computer) was determined by placing the tubing which connected the 
transducer to the pneumotachograph sideport inside an inflated balloon, 
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which was then burst. The response time was 0.8 milliseconds, giving a 
calculated frequency response of 416 Hz.  
The frequency response of the flow measurement system (consisting of the 
pneumotachograph, connecting tubing, pressure transducer for flow, 
amplifier and computer) was determined by placing one end of the 
pneumotachograph within an inflated balloon. By partially occluding the other 
end of the pneumotachograph, a constant background flow was produced, 
during which the balloon was burst. The response time was 9 milliseconds, 
giving a calculated frequency response of 37 Hz.  
The frequency response of the oesophageal and gastric pressure 
transducing system (consisting of the dual microtransducer-tipped catheter, 
amplifier and computer) was tested by placing the catheter inside an inflated 
balloon which was then burst. The response time was 3.6 milliseconds for the 
oesophageal pressure transducer and 3 milliseconds for the gastric pressure 
transducer, giving frequency responses of 92.5 Hz and 111 Hz respectively.  
2.3.4 Data acquisition and storage 
Amplified signals from the dual pressure catheter, flow and airway pressure 
transducers were displayed in real time on a laptop (Latitude CPi Dell Inc, 
Round Rock, Texas, USA) with a customised software application (Labview 
Ver 5.0, National Instruments, Austin TX, USA) with 100 Hz analogue-to-
digital sampling (16 bit DAQ card, DAQ 6036E, National Instruments, Austin, 
Texas, USA). Tidal volume data was generated within the software 
programme by digital integration of the flow signal. The data displayed in real 
time were recorded as per study protocol relating to physiological 
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measurements and stored as systematically-labelled files on the hard drive of 
the laptop for analysis. 
2.3.5 Physiological measurements 
2.3.5.1 PTPdi 
Transdiaphragmatic pressure was calculated by the digital subtraction of the 
oesophageal from the gastric pressure. PTPdi was calculated by integration of the 
transdiaphragmatic pressure signal with time for each breath and expressed per 
minute.  PTPdi recordings were carried out for a period of five minutes during quiet 
breathing. For analysis, a section of the recording providing 20 consecutive 
artefact-free breaths was selected. The Labview software calculated the PTPdi by 
digital integration of transdiaphragmatic pressure over inspiratory time (PTPdi = 










__  Green line represents airway pressure 
__  Red line represents oesophageal pressure  
__  Blue line represents gastric pressure 
__  Black line represents transdiaphragmatic pressure 
__  Purple line represents flow 
 Beginning of inspiration as denoted by flow crossing zero in the positive 
direction 
 End of inspiration as denoted by flow crossing zero in the negative 
direction 
The yellow shaded portion under the transdiaphragmatic pressure curve 
represents the PTPdi. 
 










































Pimax is the measure of maximal inspiratory pressure during crying. In ventilated, 
prematurely born infants, this was measured by disconnecting the baby from the 
ventilator and fitting a T-shaped two-way valve to the end of the 
pneumotachograph connected to the infant’s ETT tube. The inspiratory limb of the 
valve was occluded at end-expiration for five consecutive respiratory efforts 
before reconnecting to the ventilator. Three such recordings of five breaths were 
performed with an interval of a minute between each recording. The largest 
negative airway pressure generated during occlusion was recorded as the Pimax. 
If the infant desaturated or had bradycardia during the occlusion, they were 




__  Green line represents airway pressure 
__  Orange line represents flow 
Figure 2.9 Pimax trace 













































2.4 In vitro study 
2.4.1 Equipment 
2.4.1.1 Dynamic lung model 
 
The lung model was developed to represent the respiratory distress 
syndrome (RDS). Its unique aspect was that it incorporated a rigid external 
covering and a synthetic diaphragm, thus modelling a ‘pleural space’. This 
dynamic lung model consisted of a commercial lung model (SLE silicon test 
lung, part no. N6647; SLE, South Croydon, UK) mounted inside a rigid plastic 
cylinder (Figure 2.10). The commercial lung model outlet was externalised 
through the base of the cylinder and attached to the ventilator circuit via a 
pneumotachograph. The open end of the cylinder was covered by a latex 
rubber film, which represented the ‘diaphragm’. Repeated movement of the 
rubber film backwards and forwards simulated ‘diaphragmatic’ movements. 
The pressure changes within the cylinder, described as ‘pleural pressure’ 
(Ppl), were monitored from an outlet on the side of the cylinder using a 




Figure 2.10 Diagram of dynamic lung model representing RDS 
 
The compliance and resistance of the lung model were assessed using the 
Stephanie ventilator in pressure limited mode. The compliance of the lung 
model was 0.4ml/H2O and the resistance 200 cmH2O/L/sec. The resistance 
was generated by incorporating a length of narrow plastic tubing between the 




Airflow was measured by a pneumotachograph (Mercury F10L; GM 
Instruments, Kilwinning, Scotland) connected to a differential pressure 
transducer (MP45, range±2 cm H2O; Validyne, Northridge, California, USA). 













pneumotachograph was inserted between the ‘neck’ of the lung model and 
ventilator manifold. Airway pressure was measured from a side port on the 
pneumotachograph using a differential pressure transducer (MP45, 
range±100 cm H2O; Validyne). The signals from the pressure transducers 
were amplified using a carrier amplifier (CD 280; Validyne). Ppl was recorded 
using a differential pressure transducer (MP45, range±100 cm H2O; 
Validyne). The pressure and flow signals were recorded and displayed in real 
time on a computer (Dell Optiplex 170L) using Spectra® software v 3.0.0.9 
(Grove Medical, Hampton, UK) with 100 Hz analogue to digital sampling 
(PCI-MIO-16XE-50; National Instruments, Austin, Texas, USA). Calibration of 
equipment was carried out was performed as described in section 2.3.1.3 of 































Chapter 3: National survey of ventilation practice in 














There is limited evidence on the efficacy of respiratory support in infants born 
at term.  The aim of this study was to test the hypothesis that there would be 
wide variation in the use of ventilation techniques in this patient group.  A 
survey of ventilation practice in neonates born at term in the United Kingdom 
was performed. 
3.2 Methods 
An electronic web-based survey on respiratory support in neonates born at 
term was designed (Appendix A1). Lead clinicians of all neonatal units in the 
United Kingdom were identified using the BLISS directory, and contact 
details confirmed by contacting each hospital. Clinicians were sent an email 
inviting them to complete the online survey via a link. Non-respondents were 
followed up with further emails and a paper copy by post if they had not 
responded to emails. 
3.2.1 Statistical analysis 
Differences between levels of neonatal care were assessed for statistical 
significance using the Chi-squared test. Analysis was carried out using 
Graphpad Prism 5.0 (GraphPad, La Jolla, CA). 
3.3 Results 
The response rate was 82%, with 174 units of the 212 neonatal units in the 
UK providing responses. 90% of all neonatal intensive care units (NICUs), 
96% of all local neonatal units (LNUs) and 56% of all special care units 
(SCUs) in the UK replied.  
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3.3.1 Number of term newborns ventilated according to unit level  
Most NICUs (49%) and LNUs (58%) ventilated between 10 and 50 term 
newborns on an annual basis, with a large proportion of NICUs (42%) 
ventilating more than 50. The majority of SCUs (68%) ventilated less than 10 
































Figure 3.1 Percentage of units according to number of ventilated term 
newborns  
3.3.2 Ventilators used  
The three most frequently used ventilators for conventional ventilation were 
the SLE 5000, Dräger Babylog 8000/8000plus and SLE 2000. The SLE 5000 
was used by 51% of responding NICUs and LNUs and 11% of SCBUs. The 
Dräger Babylog 8000/8000plus was used by 35% of NICUs, 23% of LNUs 
and 19% of SCBUs. The SLE 2000 was used by 19% of NICUs, 26% of 
LNUs and 57% of SCBUs. Many units use more than one type of ventilator.  
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High frequency oscillatory ventilation (HFOV) was provided by all NICUs. 
Amongst NICUs, the SLE 5000 was used by 49% to provide HFOV, the 
Sensormedics 3100A was used by 47% and the Stephanie was used by 
18%. Of the responding LNUs, 48% (38 of 80 LNUs) specified they did not 
provide HFOV.  Of the LNUs that did provide HFOV, 91% used the SLE 
5000, 14% used the Dräger Babylog 8000plus/VN500 and 7% used the 
Sensormedics 3100A.  
3.3.3 Primary mode of ventilation according to diagnosis 
Units were asked to indicate which mode they would initiate ventilation for 
meconium aspiration syndrome (MAS), respiratory distress syndrome (RDS), 
persistent pulmonary hypertension of the newborn (PPHN), congenital 
pneumonia/aspiration, non-respiratory causes of respiratory failure such as 
hypoxic ischaemic encephalopathy (HIE), congenital diaphragmatic hernia 
(CDH) and gastrointestinal (GI) surgery. The responses for CDH and GI 
surgery were not analysed for LNUs or SCUs as the majority did not respond 
to this question.  
NICUs used volume-targeting significantly more than LNUs and SCUs during 
mechanical ventilation across the range of pathologies, particularly in RDS 
(p=0.0006) and congenital pneumonia (p=0.0005). In MAS and PPHN, HFOV 
was used as a primary ventilation strategy significantly more by NICUs 















     p value 
 
      
  CPAP 2 (4%) 19 (24%) 10 (27%) 0.002 
  CMV 15 (26%) 36 (45%) 16 (43%) 0.069 
  SIMV 21 (37%) 19 (24%)   8 (22%) 0.158 
MAS ACV 14 (25%) 5 (6%) 3 (8%) 0.004 
  PS 0 0 0 NA 
  Volume-targeted   8 (14%) 6 (8%) 0 0.049 
  HFOV 3 (5%) 0 0 0.044 
            
  CPAP 19 (33%) 38 (48%) 20 (54%) 0.103 
  CMV   8 (14%) 17 (21%)   9 (24%) 0.409 
  SIMV 17 (30%) 23 (29%)   5 (14%) 0.153 
RDS ACV  11 (19%) 2 (3%) 3 (8%) 0.003 
  PS 0 0 0 NA 
  Volume-targeted 15 (26%)   8 (10%) 0 0.0006 
  HFOV 0 0 0 NA 
            
  CPAP 0 8 (10%)   4 (11%) 0.043 
  CMV  17 (30%) 42 (53%) 24 (65%) 0.002 
  SIMV 17 (30%) 18 (23%)   7 (19%) 0.433 
PPHN ACV 11 (19%) 6 (8%) 2 (5%) 0.044 
  PS 0 0 0 NA 
  Volume-targeted   8 (14%) 4 (5%) 0 0.021 
  HFOV 11 (19%) 4 (5%) 0 0.001 
         
  CPAP   8 (14%) 24 (30%) 16 (43%) 0.007 
  CMV 10 (18%) 28 (35%) 13 (35%) 0.059 
  SIMV 23 (40%) 23 (29%)    6 (16%) 0.042 
Congenital   
pneumonia/ 
aspiration ACV 13 (23%) 3 (4%)  2 (5%) 0.0008 
  PS 0 0 0 NA 
  Volume-targeted 12 (21%) 4 (5%) 0 0.0005 
  HFOV 0 0 0 NA 
         
  CPAP 
       
   3 (5%) 18 (23%)   6 (16%) 0.023 
  CMV 13 (23%) 33 (41%) 20 (54%) 0.007 




HIE ACV 10 (18%) 
      
    5 (6%) 2 (5%) 0.054 
  PS 
   
 2 (3.5%) 0 0 NA 
  Volume-targeted 10 (18%) 4 (5%) 0 0.004 
  HFOV 0 0 0 NA 
 
Table 3.1 Initial mode of ventilation by diagnosis and level of neonatal care 
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3.3.4 Rescue mode of ventilation in term newborns 
Units were asked which mode they would use as rescue if a term newborn 
deteriorated on the primary mode. In the event of an infant deteriorating on 
the primary mode, CMV was utilised significantly more by LNUs and SCUs 
compared to NICUs (p<0.0001) while HFOV was utilised, significantly more 
by NICUs compared to LNUs and SCUs (p<0.0001) (Table 3.2). Thirty 
percent of LNUs and 49% of SCUs stated in the comment box that a 
deteriorating infant would be transferred to a higher level of unit.  
Units were asked if they routinely changed an infant on HFOV to 
conventional ventilation prior to extubation. Only data for NICUs were 
analysed for this question as HFOV is a mode of ventilation used mostly by 
NICUs; 61% of NICUs changed infants from HFOV to conventional 





















(n=37) p value 
      
  CMV 3 (5%) 31 (39%) 20 (54%) <0.0001 
MAS SIMV 1 (2%)   9 (11%)   8 (22%) 0.008 
  ACV 1 (2%) 11 (14%) 2 (5%) 0.032 
  HFOV 50 (88%) 27 (34%)   4 (11%) <0.0001 
            
  CMV 3 (5%) 36 (45%) 21 (57%) <0.0001 
RDS SIMV   6 (11%)   9 (11%)   9 (24%) 0.111 
  ACV 4 (7%) 10 (13%) 3 (8%) 0.527 
  HFOV 43 (75%) 22 (28%) 2 (5%) <0.0001 
            
  CMV 4 (7%) 27 (34%) 18 (49%) <0.0001 
PPHN SIMV 0 10 (13%)   7 (19%) 0.006 
  ACV 1 (2%) 7 (9%) 2 (5%) 0.221 
  HFOV 51 (90%) 30 (38%)   4 (11%) <0.0001 
            
  CMV 5 (9%) 36 (45%) 19 (51%) <0.0001 
Congenital 
pneumonia / 
aspiration SIMV 2 (4%)   9 (11%) 10 (27%) 0.003 
  ACV 3 (5%) 10 (13%) 2 (5%) 0.243 
  HFOV 44 (77%) 20 (25%) 3 (8%) <0.0001 
            
  CMV   9 (16%) 42 (53%) 21 (57%) <0.0001 
HIE SIMV 1 (2%) 11 (14%) 9 (24%) 0.004 
  ACV 5 (9%)   9 (11%) 2 (5%) 0.591 
  HFOV 38 (67%) 12 (15%) 2 (5%) <0.0001 









3.3.5 Volume-targeted ventilation (VTV) in term newborns 
26% of NICUs and 11% of LNUs, but no SCUs. indicated that they used VTV 
routinely in term newborns.  
3.3.5.1 Volume-target (VT) ranges during VTV 
Responses indicated a wide variety of VT ranges were used, with 4-6ml/kg 
and 6-8ml/kg being most commonly used in NICUs and 4-6ml/kg and 4-
5ml/kg being most commonly used in LNUs (Figures 3.2 and 3.3). For LNUs, 
the lowest VT specified was 3.5ml/kg while the highest was 10ml/kg. For 
NICUs, the lowest VT specified was 3ml/kg while the highest was 8ml/kg.  
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Figure 3.3 Commonly used volume-target ranges in LNUs 
 
3.3.5.2 Maximum Peak Inflation Pressure (PIP) 
The majority of NICUs replied they would set the maximum PIP as required, 
that is, the PIP that would enable delivery of the set tidal volume (Figure 3.4). 
Amongst LNUs using VTV, a more variable pattern was seen (Figure 3.5).  
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Figure 3.4 Maximum PIP set in NICUs 
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Figure 3.5 Maximum PIP set in LNUs 
3.3.5.3 Volume-target (VT) prior to extubation from VTV 
For both NICUs and LNUs, the median minimum tidal volume target the 






















































3.3.6 Surfactant therapy  
The routine use of surfactant for different pathologies (Figure 3.7) did not 
differ significantly between different levels of care apart from in RDS, where 























































Figure 3.7 Routine use of surfactant in term newborns 
 
3.3.7 Nitric oxide (NO) therapy in term newborns 
49 NICUs replied to this question. 55% of responding NICUs started at 
20ppm, 25% at 10ppm and 20% at 5ppm. 76% of NICUs used a maximum 
dose of 20ppm, 20% used 40ppm and 4% used 25 ppm.  
3.4 Discussion 
These results demonstrate that there was variation in practice with regard to 
respiratory support of infants born at term requiring mechanical ventilation.  
In particular, there was significant variation between hospitals providing 
different levels of neonatal care in part reflecting that in line with the BAPM 
guidelines (105), SCUs transferred infants requiring rescue respiratory 
support to a unit providing a higher level of neonatal care. Other variations in 
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practice, however, occurred between NICUs, for example, different levels of 
volume targeting or starting dose of NO.  
A recent survey reported that 60% of Australasian NICUs and 40% of 
Scandinavian NICUs routinely use VTV in prematurely born infants (82), 
perhaps reflecting the positive benefits reported in prematurely born infants in 
the recent Cochrane review (34). This survey demonstrates that 26% of UK 
NICUs routinely use VTV in term born infants, although there have been no 
randomised studies demonstrating similar benefits in term born infants.  In 
term born infants, practitioners used volume target levels from 3 to 10 ml/kg 
and the median minimum volume target weaned to before extubation was 
4ml/kg.   
A variety of ventilators were used for both conventional and high frequency 
oscillatory ventilation. It has previously been shown (81) that during VTV, 
different ventilators deliver different airway pressure waveforms, whether this 
influences outcome has not been tested. Oscillator performance also differs 
(106), the Sensormedics delivers much greater tidal volumes, particularly at 
lower frequencies.  Only 47% of units used the Sensormedics for term born 
infants indicating that less “powerful” oscillators were being used to support 
the majority of term born infants.  Whether a particular ventilator is more 
suited to the delivery of a particular mode such as VTV or HFOV in term born 
infants is unknown.  
There is no evidence to support the use of prophylactic and little to support 
use of rescue HFO in term born infants. A meta-analysis (107) of two RCTs 
comparing HFOV to conventional ventilation (CV) in term or near-term infants 
with hypoxic respiratory failure concluded there was no benefit in using 
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rescue HFOV rather than CV in term or near-term infants with severe 
respiratory failure. Clark’s study (108) did show that significantly more infants 
who met failure criteria on CV responded to HFOV compared to infants who 
failed HFOV responding to CV (p=0.03). Despite the paucity of evidence, the 
results of this survey showed high use of HFOV as initial or rescue mode by 
NICUs. As infants’ respiratory failure improves, infants on HFOV could be 
switched either to CV for further weaning prior to extubation or be extubated 
directly from HFOV. There is no evidence to support one method over the 
other in term infants, interestingly the majority of NICUs changed infants to 
CV from HFOV for a period prior to extubation.  
There is evidence to support surfactant use in certain respiratory conditions 
in term infants. In MAS in infants born at or near term, a meta-analysis 
showed that surfactant reduced the risk of requiring extracorporeal 
membrane oxygenation (ECMO) (RR 0.64, 95% CI 0.46, 0.91) (109). A 
randomised, multicentre, double-blind, placebo-controlled trial in term infants 
with severe respiratory failure (MAS, sepsis and idiopathic PPHN) (110) 
demonstrated administration of surfactant was associated with a significant 
reduction in the need for ECMO (p=0.038), but no statistically significant 
difference in the duration of ventilation or the incidence of chronic lung 
disease. A retrospective observational study (111) of 118 infants with 
respiratory failure and group B Streptococcal infection, 19% of whom were 
more than 35 weeks gestation, showed a significant reduction in the median 
fraction of inspired oxygen (FiO2) with surfactant treatment (0.84 to 0.5, 
p<0.01). Observational studies, in mostly prematurely born infants with 
pulmonary haemorrhage, showed surfactant therapy was associated with 
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improvements in severity of respiratory failure as assessed by the ventilatory 
index (VI = FiO2 x mean airway pressure / PaO2) (112) and a significant 
reduction in the mean oxygenation index (113). No benefit, however, has 
been shown of the surfactant in term infants with congenital diaphragmatic 
hernia. Indeed, in antenatally diagnosed term born CDH patients, surfactant 
treatment was associated with a higher use of ECMO (p=0.04) and incidence 
of chronic lung disease (p=0.0066) and a lower survival (p=0.0033) (114). 
Inhaled NO reduces incidence of the combined outcome of death or need for 
ECMO in ventilated, term born infants (115). Studies suggest that the 
maximal beneficial effect of NO occurs at less than 30ppm (116), as a 
consequence it has been recommended that the starting dose should be 20 
ppm (115). Just over half of the responding NICUs started at the 
recommended dose of 20ppm, with the remaining NICUs starting at lower, 
possibly suboptimal doses of 5-10 ppm.  
The survey was sent to the lead clinician for each unit, with the questions in 
the survey asking for the unit’s practice. Some responses however could 
have reflected the respondent’s personal views rather than departmental 
practice. This is a potential drawback of the study. 
In conclusion, there is variation in respiratory support practice for term born 
infants, particularly between units offering different levels of neonatal care.  
These results emphasize further research is needed to produce evidence-
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During volume targeted ventilation (VTV) a near-constant tidal volume is 
delivered, despite even rapid changes in the infant’s lung function. The level 
of volume-targeting influences the infant’s work of breathing (WOB) as 
assessed by measurement of the transdiaphragmatic pressure time product 
(PTPdi) (83, 84). Amongst prematurely born infants, in both acute respiratory 
distress (83) and during weaning (84), a volume target (VT) level of 6ml/kg 
compared to 4ml/kg was associated with a significantly lower PTPdi. Similar 
studies have not been undertaken on infants born at or near term. The aims, 
therefore, of this study were to determine, in infants born at or near term, the 
impact of different levels of volume-targeting on the WOB and, within the 
normal tidal volume range, if there was a level that reduced the WOB below 
that experienced during ventilatory support without volume-targeting.  
4.2 Methods 
4.2.1 Protocol 
Infants more than or equal to 34 weeks in gestation at birth were eligible for 
inclusion in the study, if they were supported by a time-cycled, pressure-
limited ventilator either in a continuous mandatory (CMV) or a triggered mode 
[assist control ventilation (ACV) or synchronous intermittent mandatory  
ventilation (SIMV)] and making spontaneous respiratory efforts. Infants with a 
congenital diaphragmatic hernia or severe hypoxic ischaemic 
encephalopathy were excluded.  Infants were entered into the study if their 
parents gave informed written consent.  The study was approved by the 
King’s College Hospital Research Ethics Committee.  
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All the infants were ventilated using SLE 5000 ventilators (software version 
4.3; SLE Ltd., South Croydon, UK). During volume-targeted mode (TTVplus), 
inflation was terminated once the VT level was achieved, which meant the 
delivered inflation time could be shorter than the set inflation time.  
Measurements were only carried out if the infant had blood gases in the 
normal range (pH 7.25-7.4, PaCO2 4.5-6.5 kPa).  Infants were studied first on 
their baseline ventilation, that is, without volume-targeting and then studied 
during three 20 minute periods of VTV with VT levels of 4, 5 and 6 ml/kg 
delivered in random order.  In between each period of VTV, the infants were 
returned to “baseline” ventilation for 20 minutes (Figure 4.1).    
Baseline x 20 mins
VTV
Baseline x 20 mins
Baseline x 20 mins
Baseline x 20 mins
VTV
VTV
4, 5 and 6 ml/Kg 
in random order 
each for 20 mins.
WOB assessed in 
last 5 mins
 
Figure 4.1   Flow diagram of protocol for study on optimal VT level in term 
and near-term infants 
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The WOB was assessed by measurements of the transdiaphragmatic 
pressure (PTPdi). The baseline PTPdi was calculated by averaging the PTPdi 
at the four baseline periods.  At each step, the mean expiratory tidal volume 
(VTe) of the ventilator breaths delivered during the period for which PTPdi was 
calculated and the mean peak inflation pressure during the same period were 
determined. Each infant’s spontaneous respiratory rate was calculated for the 
period from which PTPdi was derived at each VT level and the total expiratory 
minute volume (infant plus ventilator) determined.     
4.2.2. Sample Size 
Recruitment of sixteen infants allowed detection of a difference in the PTPdi 
results equivalent to one standard deviation with 80% power at the 5% level. 
4.2.3 Statistical analysis 
Differences were assessed for statistical significance using Friedman’s test 
with Dunn’s multiple comparison test. GraphPad Prism 5.0 (GraphPad, La 
Jolla, CA) was used. 
4.3 Results  
Sixteen infants with a median gestation at birth of 38 (range 34-41) weeks 
and birth weight of 3.1 (range 1.5-4.1) kg were studied at a median postnatal 
age of 5 (range 2-17) days. Five infants were supported by CMV, eight by 
SIMV and three by ACV. Two infants had meconium aspiration syndrome, 
two persistent pulmonary hypertension of the newborn, two respiratory 
distress syndrome, nine infants had surgical conditions (five gastroschisis, 
two exomphalos major, two bowel obstruction) and one infant had moderate 
perinatal asphyxia following shoulder dystocia at delivery.  At baseline, the 
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infants were receiving a median peak inflating pressure (PIP) of 16 (14-21) 
cm H2O, PEEP of 5 (4-5) cm H2O, inflation time (Ti) of 0.4 (0.34-0.5) seconds 
and an inspired oxygen fraction (FiO2) of 0.21 (0.21-0.3). All the infants were 
ventilated via shouldered ET tubes which have minimal or no leak (117). Ten 
infants were receiving morphine as an intravenous infusion of between 5 and 
10 micrograms/kg/hour at the time of the study.  
One infant with bowel obstruction studied post-operatively had a prolonged 
period of apnoea while receiving a VT level of 6ml/kg.  A capillary blood gas 
revealed a PaCO2 of 4.0 kPa. Due to the lack of spontaneous respiratory 
effort, it was not possible to measure his PTPdi at a level of 6ml/kg, thus this 
infant’s data were excluded from the analysis. At a VT level of 4ml/kg, four 
infants were making vigorous respiratory efforts and demonstrated they were 
receiving no ventilator inflations. The ventilator display, however, indicated 
the infants were receiving PIPs between 7 to 9 cmH2O, which were active 
expiratory efforts by the infants. An in vitro experiment to investigate 
increased spontaneous infant effort leading to lack of ventilator support at low 
tidal volume targets in VTV on the SLE 5000 ventilator, a phenomenon 
observed both while the study was being carried out as well on subsequent 
analysis of the traces. In this experiment, a syringe was used to mimic a 
mechanically ventilated term born infant’s spontaneous respiratory activity, 
generating tidal volumes of 20ml with the tidal volume target set at 10ml on 
the ventilator. This resulted in airway pressure deflections which, on analysis, 
revealed that the positive pressure (PIP) readings on the ventilator panel 
were actually corresponding to ‘expiratory efforts’ simulated by the pushing of 
the piston of the syringe. It was concluded that no inflation pressure was 
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being delivered by the ventilator. Inflation pressures were recorded as zero 
for the four infants in which this finding was observed.  
The mean PTPdi was higher at a VT level of 4ml/kg than at 5ml/kg (p<0.01) 
and 6ml/kg (p<0.001). The mean PTPdi was only below that at baseline at a 
VT level of 6ml/kg (p<0.01) (Table 4.1; Figure 4.2).   
The median PIP was significantly lower at VT levels of 4ml/Kg than at both 
VT levels of 5ml/kg (p<0.05) and 6ml/kg as well as baseline (p<0.001) (Table 
4.3). The median VTe was significantly higher at a VT level of 4 compared to 
5ml/kg (p<0.05).  The inflation time was lower at 4ml/kg than at baseline 
(p<0.05).  The minute volume did not differ significantly between the baseline 
and any of the VT levels.  
 










































Table 4.1 PTPdi (cmH2O.s/min) related to VT levels.  







Figure 4.2 PTPdi results with individual infant’s results shown as linked data 























































































Table 4.2 Peak inspiratory pressure (PIP), expiratory tidal volume (VTe), 
inflation time (Ti), infant spontaneous respiratory rate (RR) and 
total minute volume related to VT level.                   
                 Results are displayed as median (range). 
a, c p<0.001; b,d,e,f  p < 0.05 
4.4 Discussion 
The WOB in at or near term infants was significantly higher at a VT level of 
4ml/kg compared to both VT levels of 5ml/kg and 6ml/kg. Only a VT level of 
6ml/kg was associated with a significantly lower WOB compared to baseline, 
that is, ventilatory support without volume-targeting. The infants were 
receiving CMV or a triggered mode. The numbers on each ventilator mode 
are too small for subgroup analysis, but the data in the table (Table 4.1) 
shows a similar trend in PTPdi levels with increasing VT levels for all three 
ventilator modes.  
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Infants were studied at VT levels within the tidal volume range, that is, 4 to 
6ml/kg.  The infants studied required relatively low levels of ventilatory 
support as indicated by a maximum peak inflation pressure of 21 cmH2O and 
thus were likely to have mild respiratory failure.  Thus, we did not use VT 
levels above 6ml/kg, as, although these may have further reduced the WOB, 
their use might have resulted in volutrauma or hypocarbia.  Indeed, one 
infant had a prolonged period of apnoea at a VT level of 6ml/kg and the 
PaCO2 level was 4 kPa.  
The infants were ventilated using the SLE 5000, which during VTV 
terminates inflation short of the preset inflation time if the volume had already 
been delivered.  This, however, did not affect our results, as we used the 
same ventilator to compare the VT levels.  At a VT level of 4ml/kg, however, 
certain of the infants received an inflation time of less than 0.3 seconds and 
the inflation time was significantly shorter than at baseline.  Our finding that 
at a VT level of 4ml/kg four infants had no inflations delivered as they were 
making very vigorous efforts, further suggests this low level of VT should not 
be used in near term or term born infants. Interestingly, though the ventilator 
display recorded peak inflating pressures in those infants, these pressures 
were actually generated by the infants actively expiring.  We would suggest 
infants should be extubated from VT levels of at least 5ml/kg. 
Regardless of the VT level, the minute volume did not differ significantly.  The 
infants’ respiratory rates also did not differ significantly between VT levels.  
Those results indicate that the infant compensated for the reduced support 
from the ventilator by increasing the depth of their respiratory efforts and tidal 
volume exchange (Table 4.2) and hence their WOB was increased. 
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In conclusion, we have demonstrated that VT levels of 4ml/kg compared to 
higher levels of VT are associated with an increased WOB in at or near term 
born infants with a variety of diagnoses.  A VT level of 6ml/kg was associated 
with a reduction in the WOB below baseline, but was associated with 
hypocarbia in one infant. We conclude higher rather than lower levels of VT 
within the normal tidal volume range should be used, but it is important to 
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During volume-targeted ventilation (VTV), a constant volume is delivered with 
each ventilator inflation regardless of changes in the infant’s lung function. In 
Chapter 4 it was demonstrated that in the short term, the work of breathing 
(WOB) was reduced during VTV if higher rather than lower levels of volume-
targeting were used. Increasing the level of respiratory support by increasing 
the level of volume-targeting, however, could unfavourably impact on 
respiratory muscle strength. The aim of this study was to determine in a 
randomised study of prematurely born infants with acute respiratory distress, 
whether VTV compared to pressure-limited ventilation (PLV) using the same 
ventilator type was associated with a shorter time to reach weaning criteria. 
In addition, the study was designed to assess if any difference in the time to 
reach weaning criteria was associated with differences in the WOB or 
respiratory muscle strength between the two groups. A secondary aim of the 
study was to determine if VTV was associated with less hypocarbia 
compared to PLV.    
5.2 Methods 
5.2.1 Protocol 
A randomised trial was carried out at King’s College Hospital NHS 
Foundation Trust between August 2010 and February 2012. Infants born at 
less than 34 weeks of gestational age who were mechanically ventilated in 
the first week after birth were eligible for entry into the trial. Infants with major 
congenital anomalies, those who had been ventilated for more than 24 hours 
and/or were supported by high frequency oscillatory ventilation (HFOV) were 
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ineligible for this study.  Infants were enrolled into the study if their parents 
gave informed written consent.  The study was approved by King’s College 
Hospital Research Ethics Committee.  
Patients were randomised using sequential opaque sealed envelopes and 
random number table generation to receive either VTV or PLV. The infants in 
both arms of the trial were supported by SLE 5000 ventilators (Software 
version 4.3; SLE Ltd, South Croydon, UK). At randomisation, no changes 
were made to the ventilator settings of those infants who were to receive 
PLV. For those randomised to VTV, the only changes made were to set the 
VT level at 5ml/kg with the leak compensation at 20% and to set a maximum 
PIP that allowed a delivery of 5 ml/kg.  A VT of 5ml/kg was used, as a VT of 
at least 5ml/kg has been shown in prematurely born infants to be associated 
with a lower WOB than a VT level of 4ml/kg (83). During VTV with a SLE 
5000 ventilator, the maximum set peak inspiratory pressure was delivered to 
the infant only if the VT level was not achieved. In addition, with the SLE 
5000 ventilator, inflation is terminated once the VT level was achieved, which 
meant that the delivered inflation time might be shorter than the preset 
inflation time. In this study, if the delivered inflation time was less than 0.2 
seconds, then the waveform was altered to give a shallower upstroke to the 
inflating pressure, prolonging the inflation time. If infants developed a 
respiratory acidosis on VTV, the VT level was increased in steps of 0.5ml/kg 
to a maximum of 6ml/kg. If infants developed a respiratory acidosis on PLV, 
the rate was increased in steps of 5 breaths per minute to a maximum of 60 
breaths per minute and if necessary the pressure was increased. If those 
manoeuvres did not bring about the desired improvement in the blood gases, 
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the infant was transferred to HFOV. Infants were deemed to have failed the 
randomised mode if they required HFOV or a peak inflation pressure greater 
than 26 cmH2O or had a pulmonary haemorrhage. 
The primary endpoint was the time to reaching weaning criteria. Weaning 
criteria was defined in the PLV arm as a peak inflation pressure (PIP) of ≤ 16 
cmH2O and a fraction of inspired oxygen (FiO2) of ≤ 0.4. In the VTV arm, 
weaning criteria was defined as a VT level of 5 ml/kg with PIP ≤ 16 cmH2O. 
Those settings had to have been maintained or weaned further over the 
subsequent six hour period. Once the infants reached weaning criteria, 
caffeine was administered. In the PLV arm infants followed the unit’s routine 
practice prior to extubation, that is the infant switched to assist control 
ventilation (ACV); SIMV was only used if the infant was hypocarbic on ACV 
despite reduction in pressures but not deemed ready for extubation. In the 
VTV arm, infants were also switched to ACV/SIMV but with the intention of 
volume-targeting also being used. Throughout the study and during ongoing 
ventilation, the policy was to keep the pCO2 in the following ranges: 
4.5-5.5 kPa on days 1-2 after birth; 
5-7 kPa on days 3-7 after birth 
with the arterial pH between 7.25 and 7.35.   
After day seven permissive hypercarbia was permitted providing the pH 
remained above 7.25 on arterial or capillary blood gas assessments. 
An episode of hypocarbia was defined as a pCO2 less than 4.5 kPa on any 
blood gas measurement during the first 72 hours after birth. The number of 
arterial blood gases obtained in that time period was recorded. 
92 
 
Measurements of the WOB and respiratory muscle strength were planned for 
24 and 48 hours after randomisation on the randomised modes of ventilation 
and immediately prior to extubation. The WOB was assessed over a five 
minute period on each occasion by measurement of the transdiaphragmatic 
pressure time product (PTPdi) as previously described. Respiratory muscle 
strength was assessed by measuring the maximum inspiratory pressure 
(Pimax) and maximum expiratory pressure (Pemax) generated during an 
airway occlusion during crying. The clinicians caring for the infants were 
blinded to the results of the physiological measurements.  
The nurses recorded the level of respiratory support hourly on observation 
charts. The infants’ demographics and the levels of respiratory support at 
randomisation and pre-extubation were determined from the medical records 
and the intensive care observation charts. The duration of ventilation was the 
time from randomisation to successful extubation, that is when the infant 
remained extubated for at least 48 hours. The indications for reintubation 
were the development of a respiratory acidosis (pH < 7.25) which persisted 
for more than four hours, the occurrence of frequent apnoeas or one major 
apnoea and/or an increased oxygen requirement (FiO2 > 0.6). 
5.2.2 Sample size 
Using results from prematurely born infants previously ventilated on the unit, 
we calculated that recruitment of 40 infants allowed detection of a difference 
between the groups in the time to achieve predefined weaning criteria of 72 
hours with 90% power at the 5% level.  In addition, that sample size allowed 
us to detect a difference in the results of the physiological measurements 
equivalent to one standard deviation with 80% power at the 5% level. 
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5.2.3 Statistical analysis 
The analysis was conducted on an intention-to-treat basis. Outcome data 
were analysed using Cox regression since there was censoring of the 
primary outcome, that is, the time to achieve weaning criteria. Results are 
given as hazard ratios with 95% confidence intervals (CIs). In addition, the 
Cox model was used to estimate the median time to weaning by ventilation 
group. The results of the physiological measurements were slightly skewed, 
but transformations did not correct and so they were analysed using t tests 
but as a sensitivity analysis, tests were also done using the Mann Whitney U 
test. Binary outcomes were analysed using chi-squared or Fisher’s exact 
tests as appropriate. All analyses were conducted using Stata v11. 
5.3 Results 
There were 93 eligible infants during the study period (Figure 5.1). The 
recruited infants were of a lower gestational age than the non-recruited 
infants (median 27 weeks, range 23-34 weeks versus 29 weeks range 24-34 
weeks respectively) p = 0.022 and were of lower birth weight (median 916g, 
range 500-2122g versus 1190g, range 545-2526g respectively) p = 0.014.  
There was no evidence of imbalance in the demographic data of the infants 
randomised to the PLV or VTV group (Table 5.1). When the infants reached 
weaning criteria, 18 infants in the VTV arm were switched to ACV (15 with 
volume targeting) one to SIMV and one infant died before extubation. The 
ventilator settings immediately after randomisation were similar in the two 
groups (Table 5.1). In only two infants it was necessary to increase the VT 
level above 5ml/kg because the infants developed a respiratory acidosis.        
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There were no significant differences in the time to achieving weaning criteria 
median 14 hours (VTV) versus 23 hours (PLV); hazard ratio = 0.82 (95% CI 
0.42, 1.58, p = 0.055) (Figure 5.2), the time to successful extubation or the 
number of infants in each group who met failure criteria (Table 5.2). The 
ventilator settings at extubation were similar in the two groups (Table 5.2).    
For logistical reasons and that the majority of infants reached weaning 
criteria prior to 24 hours after randomisation few infants had measurements 
at 24 and 48 hours (n=7, n=4 respectively) and thus those results are not 
reported. There were no significant differences between the two groups in the 
median PTPdi, Pimax or Pemax results pre-extubation (Table 5.3). The only 
significant difference in other outcomes was that fewer infants in the VTV 
compared to the PLV arm had episodes of hypocarbia (8 versus 19, p<0.001) 
(Table 5.4). The number of blood gases obtained in the first 72 hours after 
birth was similar in each group (Table 5.4). 
5.4 Discussion  
The study has demonstrated that there was no significant difference in the 
time to reach weaning criteria in prematurely born infants with acute 
respiratory distress supported by PLV or VTV. The time to reach weaning 
criteria was chosen as the primary outcome as we wished to determine 
whether VTV compared to PLV had favourable effects during the period 
when the infants had acute respiratory distress. Our sample size allowed us 
to detect a difference in the time to reach weaning criteria of 72 hours (with 
90% power), but unexpectedly the majority of infants in both groups met the 
weaning criteria within 72 hours. Our sample size, however, was also 
powered to detect a difference in the results of the physiological 
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measurements equivalent to one standard deviation and we demonstrated no 
significant differences in the pre-extubation WOB or respiratory muscle 
strength results. Those measurements were made when the infants had 
been transferred to ACV/SIMV for weaning from ventilatory support, but the 
majority in the VTV arm remained additionally on volume-targeting. Our 
results then reflect that a combination of PLV and ACV/SIMV was associated 
with similar levels of WOB and respiratory muscle strength as a combination 
of VTV and ACV/SIMV with volume targeting.   
Our data suggest that VTV as used in this study and PLV provide similar 
levels of respiratory support to prematurely born infants with acute respiratory 
distress. Indeed, immediately after randomisation, the peak inflation pressure 
and inflation times did not differ between the two groups. We used a VT level 
of 5ml/kg and it is possible if we had used a higher level, we may have had 
different results. In a previous study, however, a VT level of 6ml/kg was not 
associated with a WOB that was significantly less than at baseline, ie no VT 
(83). We were reluctant to use a higher VT level than 6 ml/kg as studies in 
prematurely born lambs have shown “dose”-dependent lung damage with 
increasing volume delivery (118). In addition, although a wide range of VT 
levels were used in the studies included in the meta-analysis (34), the most 
common VT level used was 5ml/kg. Only two infants required an increase in 
VT levels above 5ml/kg because they developed a respiratory acidosis 
further suggesting that a VT level of 5ml/kg was appropriate. 
In the meta-analysis reported in the Cochrane database, the duration of 
ventilation was shorter in the VTV arm. In this RCT, the median duration of 
ventilation was twice that in the PLV compared to the VTV arm. Of note, the 
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ventilator settings immediately prior to extubation were similar and thus the 
clinicians had not biased the results by extubating the VTV group “sooner”.  It 
should be noted, however, that this difference was not statistically significant 
and our sample size was not calculated to detect a difference in the duration 
of ventilation. 
The secondary outcomes of PDA, pneumothorax, IVH > grade 3, cystic PVL 
and BPD are reported only to give the reader more information regarding the 
population we studied. The episodes of hypocarbia did differ significantly 
between the two groups. This seems unlikely to be by chance given the level 
of significance and the limited number of secondary outcomes. In addition, 
the number of blood gases obtained during the first 72 hours did not differ 
significantly between the two groups, so the difference in the number of 
episodes of hypocarbia was genuine. This is an important finding, as 
hypocarbia in prematurely born infants is significantly associated with the 
development of PVL and adverse neurodevelopmental outcomes (36, 37). 
Thus, despite finding no difference in our primary outcome, we would 
recommend VTV in prematurely born infants with acute respiratory distress 
as a means of reducing hypocarbia.   
Our study has a number of strengths and some limitations. The same 
ventilator type was used in both arms of the study; performance has been 
shown to differ according to type of ventilator with regard to airway pressure 
waveforms (81). We recruited consecutive infants who fulfilled the eligibility 
criteria and a researcher was available. The recruited and non-recruited 
infants, however, differed significantly in that those who were not recruited 
were significantly more mature and of greater birth weight. Their non-
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recruitment likely reflects that such infants frequently require a shorter 
duration of ventilation and hence there would be less time to inform the 
researcher and they might achieve the primary outcome/extubation before 
consent can be taken. In addition, parents may have been less likely to 
consent to a ventilation study of acute respiratory distress if their infant’s 
respiratory status was rapidly improving. We emphasize then that our results 
apply to very prematurely born infants. There were no significant differences 
in the peak inflating pressures and inflation times or inspired oxygen 
concentrations between the two groups either immediately following 
randomisation or pre-extubation. Those results were from the nursing 
observation charts rather than analysis of continuous electronic recordings.  
The nurses, however, made the recordings according to the unit’s policy, that 
is, they made the observations at hourly intervals. It thus seems unlikely they 
would have biased the results. The clinicians were not blinded to the 
intervention and indeed were not in any of the studies included in the meta-
analysis, as carrying out a blinded ventilation study is difficult and would 
require additional staff. The lack of significant differences in most of our 
results would suggest that the lack of blinding had not influenced 
performance of the study.   
In conclusion, in prematurely born infants with acute respiratory distress, VTV 
compared to PLV did not improve the time to reach weaning criteria or the 
results of physiological assessments. The significant reduction in episodes of 
hypocarbia in the VTV versus the PLV group suggests VTV might improve 
long term outcome. That hypothesis needs to be assessed in an 
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Table 5.1 Demographics by mode of ventilation. 















Table 5.2 Outcomes by ventilation mode. 
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162.30 (77-295), 8 
 
 
















14.5 (7.4-35.4), 10 
 
17.7 (4.2-45.6), 8 
 
0.89 
Table 5.3 Results of the physiological measurements pre-extubation by 
ventilation mode. Data shown as median (range) and the number of infants 




































































































































Table 5.4 Other outcomes 
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Kaplan Meier graph: time to weaning by ventilation in 40 infants
 
 




























































Neonates often breathe while being mechanically ventilated. There is very 
little in the current literature on optimisation of ventilation using patient-
ventilator interactions as an outcome. During analysis of recordings 
measuring work of breathing in term-born infants for this thesis, it became 
evident from visual inspection of the traces that there existed definite 
interactions of the type described by Greenough et al in ventilated preterm 
infants in the 1980s (31, 119). This study describes and classifies 
spontaneous respiratory efforts in mechanically ventilated infants born at or 
near term. Comparisons are made between non-triggered and triggered 
modes on PLV and on VTV at different volume-target levels to determine if 
there were significantly less asynchronous interactions in any group. 
6.2 Methods 
6.2.1 Protocol 
Data were examined from recordings taken for the primary purpose of 
measuring the work of breathing. These recordings provided a graphical 
representation of airway pressure, flow, oesophageal and gastric pressures 
which could be visually analysed to describe and classify patient-ventilator 
interactions. Recordings from periods during which infants were receiving 
time-cycled, pressure-limited ventilation on CMV or SIMV or different levels 
of volume targeted ventilation were examined. Each infant had at least 20 
minutes of recordings from which the first section of trace free of peristaltic 
artefact was chosen which had one hundred consecutive spontaneous 
breaths. For comparison at different levels of volume-targeting, fifty 
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consecutive breaths at each level of volume-targeting were analysed. This 
was because at 4ml/kg, the pressure delivered by the ventilator was 
sometimes minimal, making it difficult to distinguish the presence of a 
mechanical breath.  
All infants were studied in the supine position, spontaneously breathing while 
ventilated, but on variable levels of sedation, ranging from none to 10 
micrograms/kg/hr of morphine sulphate as an intravenous infusion. Ventilator 
settings were determined by the clinical team caring for the infants and not 
changed by the researcher.  
The start and end of inspiration and expiration were determined by visual 
inspection of the flow trace. Inspiration started and expiration ended at the 
point when flow crossed zero and became positive, and inspiration ended 
and expiration started at the point when flow crossed zero and became 
negative. The change in flow could be brought about either by the ventilator 
(passive) or the baby (active). This could be determined by determining the 
temporal relationship of changes in the airway pressure trace reflecting 
mechanical ventilator cycles, to the oesophageal pressure trace reflecting 
spontaneous infant effort. 
6.2.2 Patterns of patient-ventilator interaction 
Five patterns of patient-ventilator interaction were delineated – synchronous, 





6.2.2.1 Synchronous inspiration 
Synchronous inspiration (Figure 6.1) constituted a pattern where 
spontaneous inspiration coincided with the mechanical inflation, with no 
alteration of ventilator flow. The start of the mechanical inflation, represented 
by the upward deflection of the pressure waveform, coincided with the 
negative deflection of the oesophageal pressure waveform which 
represented the start of spontaneous inspiratory effort. During the inflation, 
the flow waveform remains positive as there is no opposition to inspiratory 
flow. A small and positive gastric pressure deflection may also be noted, 
which accompanied the negative oesophageal deflection during a 
spontaneous infant inspiratory effort. 
 
Figure 6.1 Synchronous inspiration 
__  Green line represents airway pressure 
__  Red line represents oesophageal pressure  
__  Blue line represents gastric pressure 
__  Orange line represents flow 
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6.2.2.2 Active expiration 
Active expiration (Figure 6.2) was a pattern of patient-ventilator interaction 
where the infant’s expiratory effort against the ventilator inflation brought flow 
to zero or reversed flow during the inflation. During the inflation, there was a 
positive deflection in the oesophageal pressure waveform, as well as the 
gastric pressure waveform, representing the infant’s active expiratory effort. 
The effort against the inflations delivered by the ventilator reversed the 
direction of gas flow, resulting in no flow or an expiratory flow pattern during 
inflation. 
 
Figure 6.2 Active expiration  
__  Green line represents airway pressure 
__  Red line represents oesophageal pressure  
__  Blue line represents gastric pressure 




6.2.2.3 Prolongation of expiration 
In this pattern, the mechanical inflation was associated with prolongation of 
passive expiration (Figure 6.3). Expiration was classified as passive as the 
inspiratory flow generated by inflation was not affected. The small positive 
gastric pressure deflections were probably associated with the rise in intra-
abdominal pressure secondary to lung inflation. 
 
 
Figure 6.3 Prolongation of expiration 
__  Green line represents airway pressure 
__  Red line represents oesophageal pressure  
__  Blue line represents gastric pressure 





6.2.2.4 Augmented inspiration 
This pattern consisted of pronounced inspiratory efforts coincident with 
inflations (Figure 6.4). The augmented inspirations were characterised by 
large negative deflections in oesophageal pressure with an accompanying 




Figure 6.4 Augmented inspiration  
 
__  Green line represents airway pressure 
__  Red line represents oesophageal pressure  
__  Blue line represents gastric pressure 






Apnoea was said to occur when there was no evidence of spontaneous 
inspiratory or active expiratory effort by the ventilated infant (Figure 6.5). 
Small elevations in both oesophageal and gastric pressures were seen to 
occur coincident with the inflation, as a result of the increase in intra-
abdominal and intrapleural pressures during lung inflation occurring in the 
absence of diaphragmatic contraction.  
 
Figure 6.5 Apnoea  
 
__  Green line represents airway pressure 
__  Red line represents oesophageal pressure  
__  Blue line represents gastric pressure 




6.2.3 Statistical analysis 
Differences were assessed for statistical significance using the Chi-squared 
test. Statistical analysis was carried out with GraphPad Prism 5.0 (GraphPad, 




6.3.1 Comparison of interactions on CMV and SIMV 
Twelve infants with a median gestational age of 38 weeks and a median 
birthweight of 3.1 kg were studied at a median postnatal age of five days.  
Six of the 12 infants were on continuous mandatory ventilation (CMV) and six 
were on synchronised intermittent mandatory ventilation (SIMV).  
Synchronous breaths were significantly higher on SIMV than on CMV 
(p=0.003). Active expiration was significantly higher on SIMV than on CMV 
(p<0.001). The proportion of breaths with prolongation of expiration was 
significantly higher on CMV than on SIMV (p<0.001). There was no 
significant difference in the occurrence of augmented inspirations between 


















































Table 6.1 Distribution of interactions across each mode (expressed as 
percentages of interactions within total breaths analysed) 
 
6.3.2 Comparison of different levels of volume targeting 
Fifteen infants with a median gestational age of 38 weeks and a median 
birthweight of 3.1 kg were studied at a median postnatal age of 5 days. Five 
of the fifteen infants were on continuous mandatory ventilation (CMV), seven 
were on synchronised intermittent mandatory ventilation (SIMV) and three 
were on assist/control ventilation (ACV). In four of the neonates (one neonate 
on CMV, three on triggered ventilation), during ventilation at the volume-
target of 4ml/kg, no ventilator breaths were being delivered. This occurred in 
cases where the infant’s spontaneous effort was so vigorous, that the tidal 
volume per breath was easily generated by the infant alone, and the 
ventilator provided only the set PEEP and perhaps a PIP of 1-2 cm of H2O 
above it (Figure 6.6). Data from these neonates were excluded from 






Figure 6.6 Peak inflation pressures of 7 cm of H2O (PEEP 5) at VT 4ml/kg 
 
Patient-ventilator interactions from four neonates on CMV and seven 
neonates on SIMV were analysed (Table 6.2). Synchronous interactions 
were significantly more common at VT of 4ml/kg compared to no VT or VT of 
6ml/kg (p<0.0001). Synchrony was also more common with no VT compared 
to 6ml/kg (p=0.0003). Active expiration was more common with no VT 
compared to VT of 6ml/kg (p=0.02). Prolonged expiration was more common 
with no VT (p=0.03) and VT of 6ml/kg (p<0.0001) compared to VT at 4ml/kg, 
and also more common at 6ml/kg compared to no VT (p<0.0001). 
Augmented inspirations were uncommon and did not differ significantly 
between VT levels. Apnoea was significantly less common when infants were 






























16 46 29 2 7 
Table 6.2 Percentages of patient-ventilator interactions by VT level (n=11) 
Active expiration was significantly more common during mandatory 
ventilation than triggered ventilation at a VT level of 4ml/kg (p<0.0001). 
Active expiration was significantly more common during triggered ventilation 
when no VT or VT of 6ml/kg were used (p<0.0001 and p=0.003 respectively) 
(Table 6.3).  
 
    
 
 
Percentage of interactions classified as active 


















39 50 0.003 
Table 6.3 Comparison of active expiration during mandatory and triggered 




This study has demonstrated that the spontaneous respiratory efforts of 
mechanically ventilated infants born at or near term show distinct interactions 
with ventilator inflations. Some patterns of interaction fit with known neonatal 
respiratory reflexes such as the Hering-Breuer reflexes and Head’s 
paradoxical reflex. This has previously been demonstrated in prematurely 
born ventilated infants (31), but  to my knowledge the first time it has been 
described in a ventilated term population. Respiratory reflexes have been 
described in non-ventilated infants born at term (120), and while the reflexes 
have been shown to become more difficult to stimulate with increasing 
postnatal age (119, 121) the infants in this study were studied at a median 
postnatal age of 5 days. Augmented inspirations are known to be more 
frequent soon after birth, tailing off with postnatal age (100, 122), which fits 
with the low incidence of augmented inspirations noted in this study. It is 
highly probable that the patterns of interaction described in this study are 
produced due to provocation of respiratory reflexes by mechanical inflations.  
It is appreciated that a drawback of this study is the small numbers of 
patients within the groups compared. Only at 4ml/kg was active expiration 
significantly less on triggered ventilation. An explanation for this phenomenon 
might be that the suboptimal volume-target caused the infants to make efforts 
to supplement their minute volume, in response to which the ventilator 
delivered low inflation pressures over shorter inflation times as the volume 
target was achieved or exceeded by infant effort. The low inflation pressure, 
delivered within a period that did not extend into the infant’s natural 
expiratory phase, would be unlikely to provoke an active expiration. 
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Whether or not a particular kind of patient-ventilator interaction is associated 
with a particular clinical outcome would be a useful question that this study 
did not address. Active expiration in prematurely born infants is associated 
with pneumothoraces (62), but none of the infants in this study developed a 
pneumothorax. Active expiration did occur on SIMV - this likely reflects that 
during SIMV inflation may extend into expiration. It would be interesting to 
assess infant-ventilator interactions on pressure-support ventilation (PSV), as 
by design, PSV allows the infant to control the onset of the ventilator’s 
expiratory cycle. 
In terms of implications for clinical practice, this study demonstrates that use 
of conventional triggered modes such as SIMV and ACV does not 
necessarily mean more synchronous patient-ventilator interactions. 
Spontaneously breathing infants ventilated with triggered modes with VT at 
the lower end of the physiological range experience lower rates of active 


































Chapter 7: In vitro study of the effect of proportional 

















7.1 Introduction  
The aim of this study was to determine the effects of increasing elastic and 
resistive unloading, using pressure-volume curves constructed from tidal 
volumes and both airway and “pleural” pressure, to help define optimal 
settings for clinical practice. 
7.2 Methods 
7.2.1 Protocol 
The dynamic lung model, incorporating a ‘pleural space’ and manually 
retractable ‘diaphragm’, was designed to represent respiratory distress 
syndrome (RDS). The model is described in detail in the methods chapter. 
The compliance and resistance of the lung model were 0.4ml/H2O and 200 
cmH2O/L/sec respectively.  
7.2.1.1 Elastic Unloading 
The ventilator (Stephanie® neonatal ventilator; F Stephan, Gackenbach, 
Germany) was then changed to PAV mode with an airway pressure limit of 
25 cmH2O and PEEP of 5 cmH2O. The airway pressure limit was imposed to 
avoid ‘runaway pressures’ (progressive increase in inflation pressure with 
every breath due to positive feedback) that can occur with overcompensation 
for elastic unloading (85). During PAV, the ‘diaphragm’ was retracted 
manually at least 10 times to simulate breathing efforts, generating tidal 
volumes as close as possible to 3 ml (i.e. 6ml/kg for a 500g baby)  The tidal 
volume displayed on the ventilator was used to guide the extent of the 
retraction of the rubber film.  
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Baseline assessments were made with elastic unloading and resistive 
unloading at zero. Measurements were repeated after the elastic unloading 
was increased in steps of 0.5 cmH2O/ml until the elastic unloading was 
equivalent to 2.0 cmH2O/ml.  
Pressure-volume loops were constructed on 5 consecutive inflations at each 
level of elastic unloading for the ventilator inflations and for the lung model 
and work of breathing calculated by dividing the aggregate of the tidal volume 
and inflation pressure by two (123). The result was then divided by the tidal 
volume to correct from errors due to differences in inflation volumes. 
7.2.1.2 Resistive unloading 
The procedure described above was repeated but with the elastance 
unloading maintained at zero, while the resistive unloading was increased by 
25 cm H2O/L/sec increments up to 200 cm H2O/L/sec. 
A computer program (LabChart7, ADInstruments, Dunedin, New Zealand) 
was used to measure the inspiratory resistive work of breathing i.e. the area 
of the pressure-volume loop above the inspiratory-expiratory line (124), again 
on 5 consecutive inflations. 
7.2.2 Measurements 
Airflow was measured by a pneumotachograph (Mercury F10L; GM 
Instruments, Kilwinning, Scotland) connected to a differential pressure 
transducer (MP45, range±2 cm H2O; Validyne, Northridge, California, USA). 
Tidal volume was obtained by digital integration of the flow signal. The 
pneumotachograph was inserted between the endotracheal tube (ETT) and 
ventilator manifold. Airway pressure was measured from a side port on the 
pneumotachograph using a differential pressure transducer (MP45, 
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range±100 cm H2O; Validyne). The signals from the pressure transducers 
were amplified using a carrier amplifier (CD 280; Validyne). Ppl was recorded 
using a differential pressure transducer (MP45, range±100 cm H2O; 
Validyne). The pressure and flow signals were recorded and displayed in real 
time on a computer (Dell Optiplex 170L) using Spectra® software v 3.0.0.9 
(Grove Medical, Hampton, UK) with 100 Hz analogue to digital sampling 
(PCI-MIO-16XE-50; National Instruments, Austin, Texas, USA). 
7.2.3 Statistical analysis 
All statistics were carried out using Microsoft Excel 2007 (Microsoft 
Corporation, Redmond, WA, USA). 
7.3 Results 
The median tidal volume generated by the retraction of the diaphragm was 
3.8 ml (range 3.1-4.4ml) during elastic unloading and was 3.4 ml (range 2.4-
4.3ml) during resistive unloading. 
7.3.1 Elastic unloading 
The elastic WOB corrected for tidal volume provided by the ventilator rose 
from 0.18 (SD 0.09) gm.cm/ml with zero unloading to 3.75 (SD 0.24) g.cm/ml 
with unloading of 2.0 cm H2O/ml in a linear manner. The corresponding WOB 
measurements from the pressure-volume curves of the lung model fell from 
7.53 (SD 0.48) to 2.17 (SD 0.39) g.cm/ml (Table 7.1, Figure 7.1). Although 
these reductions were also linear, the WOB of the lung model fell 
approximately 30% more than the corresponding increase in the WOB 
provided by the ventilator. The pressure-volume loops showed considerable 
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deviation from the patterns expected if the ventilator’s rise in inflation 
pressure exactly matched the tidal volume (Figs 7.3-7.7). 
 
  
Level of elastance unloading (cm H2O/ml) 
  
None 0.5 1.0 1.5 2.0 
Elastic WOB 
(g.cm/ml) 
Lung model 7.53 6.57 4.60 3.29 2.17 
Ventilator 0.18 1.12 1.97 3.15 3.75 
Table 7.1 Work of breathing for lung model and ventilator with increasing 
levels of elastic unloading corrected for tidal volume delivered 
 
Fig 7.1 Changes in WOB for the lung model and ventilator with increasing 




7.3.2 Resistive unloading 
The resistive WOB provided by the ventilator rose from 0.28 (SD 0.16) g.cm 
with zero unloading to 7.17 (SD 1.4) g.cm with resistive unloading of 200 cm 
H2O/L/sec. This rise was approximately linear. The resistive unloading of the 
lung model showed an almost random pattern with a higher WOB of 9.5 (SD 
1.85) g.cm at 200 cm H2O/L/sec compared to 6.82 (SD 1.3) at zero unloading 
(Table 7.2, Figure 7.2). These results were due to the complex pressure 
volume loops of the lung model (Figs 7.8-7.16) and the relatively low inflation 





Table 7.2 Work of breathing for lung model and ventilator with increasing 
levels of resistive unloading corrected for tidal volume delivered  
 
 
Figure 7.2 Changes in WOB for the lung model and ventilator with increasing 
levels of resistive unloading 
 
 
   
Level of resistance unloading (cm H2O/L/sec) 
   
   




WOBmodel 6.82 10.15 12.58 8.53 8.99 7.65 3.37 6.49 9.5 




This study demonstrates that although during elastic unloading there are 
complex pressure-volume loops PAV is very effective in reducing elastic 
WOB. In contrast, no benefit was demonstrated from resistive unloading.  
The success of the elastic unloading was surprising in view of the trigger 
delay and the differences in oesophageal and airway pressure wave forms 
demonstrated in our previous publication and are responsible for the complex 
pressure volume loops demonstrated in Figs 7.3-7.7. In the previous 
publication the fall in oesophageal pressure with increasing elastic unloading 
closely matched the rises in airway pressure. It is likely that the complexity of 
the pressure-volume curves of the lung model led to an under calculation of 
the WOB as elastic unloading is increased. This would explain why the WOB 
of the lung model falls by approximately 30% more than the increase in WOB 
provided by the ventilator.  
Although the ventilator appeared to perform well, increasing inflation 
pressures appropriately with increasing levels of resistive unloading, it was 
not possible to demonstrate any consistent or significant corresponding fall in 
WOB in the lung model. This may be due to the complex pressure-volume 
loops in the lung model. Also, although the resistance was high the main 
WOB component was elastic and more promising results may have been 
found in a high compliance and high resistance model. It is however difficult 
to think of any clinical neonatal respiratory problem which would generate 
this situation. In conclusion, these data provide further evidence that PAV is 
highly effective in reducing the elastic WOB and has a role in neonatal 
























































































































































































































8.1 Results from this thesis and the current literature 
8.1.1 National survey 
This survey provides an overarching picture of clinical practice focussed on 
respiratory support provided to infants born at term by neonatal units across 
the United Kingdom. There are no other published surveys to date focussing 
exclusively on the respiratory management of term born infants. Dani’s 
survey (125) focussed on the respiratory management of infants with RDS 
admitted to Level 3 NICUs in Italy; it does not differentiate between  
prematurely born and term infants, but the focus on RDS suggests that the 
data would relate more to management of prematurely born babies as RDS 
is more common in this group (11). Though the surveys were structured 
differently, in infants with RDS cared for on NICUs, Dani’s study compared to 
the one reported in this thesis reports less use of CMV (8% versus 14%), 
SIMV (13% versus 30%) and VTV (18% versus 26%), similar use of ACV 
(21% versus 19%) and greater use of HFOV (4% versus 0%).  
8.1.2 Volume-targeted ventilation 
An assessment of WOB at different levels of volume-targeting in term born 
infants demonstrated that 5ml/kg was an optimal volume target, being 
associated with significantly less WOB than at 4ml/kg and without the risk of 
apnoea secondary to hypocarbia noted at 6ml/kg. An RCT comparing VTV to 
PLV in prematurely born infants did not demonstrate any difference in time to 
weaning but VTV was associated with significantly less hypocarbia. 
Neumann (126) demonstrated a negative association of respiratory dead 
space (defined as the combined anatomical and appliance dead space) and 
gestational age in a prematurely born cohort, with dead space of the 
142 
 
ventilatory equipment contributing substantially to respiratory dead space. If 
volume-targets are set at a particular level, then changes in dead space with 
gestation will impact accordingly on the effective tidal volume. These findings 
should be taken into consideration when designing future trials assessing 
VTV.  
Peng’s recent systematic review and meta-analysis of studies comparing 
VTV to PLV (127), assessed eighteen studies, one of which was excluded 
from the Cochrane review (128) and five of which were not included in the 
Cochrane review (129-133). Of those studies, one (129) is a publication 
accessible only via China National Knowledge Infrastructure. Swamy’s study 
(130) is an evaluation of further outcomes from data collected as part of an 
earlier RCT (134). Liu’s study (131) is published in Chinese with an abstract 
available in English – it was an RCT of newborns with severe RDS, 
comparing SIPPV + volume guarantee (delivered by the Dräger Babylog 
8000-plus) with HFOV (delivered by the Sensormedics 3100A) and pressure-
limited IMV (Delivered by the VIP Bird). The infants studied ranged in 
gestation from 27 to 35 weeks, which brings part of the patient population 
into the ‘near-term’ category. The RCTs of Duman (132) and Guven (133) 
both compared VTV (volume guarantee) to PLV in prematurely born infants 
with RDS using the Dräger Babylog 8000-plus. The new result demonstrated 
by the Peng meta-analysis is the significant reduction in the incidence of BPD 
(defined as oxygen dependency at 36 weeks postmenstrual age). In the 
randomised study comparing VTV to PLV described in Chapter 5, there were 
significantly fewer episodes of hypocarbia in the first 72 hours in the VTV 
arm. This is in keeping with results from both meta-analyses (34, 127). 
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Outcome  Wheeler, 2010  Peng, 2014 
Death 
RR 0.80  
[95% CI 0.53, 1.20] 
RR 0.73  
[95% CI 0.51, 1.05] 
Incidence of BPD  
(36 weeks) 
RR 0.73  
[95% CI 0.53, 1.00] 
RR 0.61  
[95% CI 0.46, 0.82] 
Mechanical ventilation 
(days) 
MD -2.36  
[95% CI -3.90, -0.83] 
 MD −2.0  
[95% CI -3.14 to -0.86] 
 Grade 3/4 IVH 
RR 0.71  
[95% CI 0.45, 1.11] 
RR 0.55  
[95% CI 0.39, 0.79] 
PVL 
RR 0.41  
[95% CI 0.15, 1.16] 
RR 0.33  
[95% CI 0.15, 0.72] 
Pneumothorax 
RR 0.46  
[95% CI 0.25, 0.84] 
RR 0.46  
[95% CI 0.25, 0.86] 
Hypocarbia (episodes) 
 RR 0.56  
[95% CI 0.33, 0.96] 
 RR 0.56  
[95% CI 0.33, 0.96] 
 
Table 8.1 Comparison of the results of the two systematic reviews (34, 127) 
RR - Risk Ratio 
CI - Confidence Interval 
MD - Mean Difference 
8.1.3 Patient-ventilator interactions 
Chapter 6 describes interactions of term born infants with mechanical breaths 
in patterns which may be explained by respiratory reflexes. Newer modes of 
ventilation such as pressure support, proportional assist ventilation (PAV) 
and neurally adjusted ventilatory assist (NAVA) may offer greater 
opportunities for patient-ventilator synchrony. NAVA uses an array of 
electrodes mounted on a nasogastric tube to generate a diaphragmatic 
electromyography signal also known as electrical activity of the diaphragm 
(Edi). The Edi signal is transmitted to the ventilator via electronics embedded 
in the nasogastric tube. The ventilator responds by providing an inflation 
pressure is directly and linearly in proportion to the Edi. All aspects of the 
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mechanical breath delivered correspond to the Edi, thus providing, in theory, 
a breath perfectly tailored to the patient’s demand. A crossover study (135) 
infants and children ventilated on PICU showed that compared to PSV, 
NAVA was associated with a significantly lower asynchrony index.  
8.1.4 Proportional Assist Ventilation 
In the in vitro study described in Chapter 7, a lung model mimicking RDS was 
used to assess the efficacy of stepwise increases in elastance and resistance 
unloading. Elastance unloading was more effective than resistive unloading 
and in infants with low compliance and high resistance, unloading elastance 
may be a preferential strategy when using PAV. Unloading resistance should 
be approached with caution, as, in addition to the lack of efficacy in reducing 
WOB demonstrated in this study, a previous in vitro study (90) demonstrated 
oscillations in the airway pressure waveform when unloading high levels of 
resistance (more than 100 cm H2O/L/s). 
Bhat’s recent clinical crossover study (136) has demonstrated that in preterm 
infants, PAV with unloading of elastance by 100% was associated with 
significantly lower oxygenation index, WOB and increased respiratory muscle 
strength compared to ACV.  
8.2 Strengths and weaknesses of studies 
8.2.1 Survey 
A good response rate was achieved, overall of 82% of all the neonatal units 
in the UK, including 90% of the Neonatal Intensive Care Units (NICUs) and 
96% of the Local Neonatal Units (LNUs), but only 56% of the Special Care 
Units (SCUs). The majority of responding SCUs indicated they ventilated less 
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than ten term newborns per year. Our survey was comprehensive yet 
concise enough to encourage a complete response. As a result, we were 
able to obtain an overview from a wide cross-section of UK neonatal units on 
their approach to respiratory support in term newborns, considering a variety 
of pathologies and modes of support.  
Most surveys of this nature have focussed on units providing a higher level of 
intensive care (125, 137). We chose to approach all levels of neonatal unit 
because the need for mechanical ventilation of a term infant may arise in any 
care setting.  
Volume-targeted ventilation is being used in term-born infants with a variety 
of pathologies, despite the lack of an evidence-base to support this practice. 
It appears that the evidence-base that exists for prematurely born infants is 
being extrapolated to the term infant population. It is imperative that studies 
focussing on optimisation of VTV in term-born infants are carried out, and the 
study in this thesis addressed that need.  
8.2.2 Volume-targeted ventilation 
We chose to use volume-target levels of 4, 5 and 6 ml/kg, as term infants 
have a similar range of physiological tidal volumes to preterm infants (138, 
139). We established that 5ml/kg was an optimal tidal volume to target in 
term infants with respect to work of breathing. Caution should be exercised 
when using 6ml/kg as it may cause hypocarbia which is known to be 
associated with adverse outcomes in term infants (38, 39).  
In the majority of randomised studies to date, Dräger’s volume guarantee has 
been assessed as the VTV intervention (54, 131-133, 140-144). In this 
thesis, the TTVplus mode delivered by the SLE 5000 ventilator has been 
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studied as part of an RCT. The SLE 5000 ventilator is widely used in the 
United Kingdom (145), therefore this study is relevant to clinical practice.  
8.2.3 Patient-ventilator interactions 
The term ‘patient-ventilator interaction’ has broad usage, and has been used 
to reflect work of breathing (146) and variance in tidal volume delivery (147). 
The study in Chapter 6 may be the first description of patient-ventilator 
interactions in ventilated term-born infants, reflecting the possible role of 
respiratory reflexes. Patient-ventilator interactions have been the focus of 
previous studies assessing new modes of ventilation, such as the 
comparison of flow-triggered and pressure-triggered SIMV (146) and testing 
the prototype for the first volume guarantee algorithm (147). The study in 
Chapter 6 was not designed to take into account association of particular 
patterns of interactions with clinical outcomes; this is a drawback. The 
comparisons were not made according to power calculations, which is a 
limitation due to the opportunistic nature of this study. Data from this study 
could be used as pilot data to inform power calculations for future studies of 
newer modes of ventilation aiming to reduce asynchronous interactions or 
promote synchrony. 
8.2.4 In vitro study of PAV 
The ventilator display was used to determine compliance and resistance of 
the lung model. A study by Abbasi (148) assessing accuracy of tidal volume, 
compliance and resistance values as displayed by five different ventilators 
showed that there was considerable variation in the computation of these 
variables. The Stephanie, which was the ventilator used in our study, was not 
assessed in Abbasi’s study. PAV delivered with the Stephanie would, by 
147 
 
design, require utilisation of the values of compliance and resistance 
provided by the ventilator display. Our study did not include a verification of 
the Stephanie ventilator’s accuracy in measuring these parameters. Verifying 
the compliance and resistance of the lung model independently and using 
those values to guide the degree of elastic and resistive unloading would not 
have been pragmatic, as in clinical practice it would not be feasible to carry 
out the measurement of the compliance and resistance separately and use 
those values instead of the ones on the ventilator display.  
8.3 Future research 
Despite a systematic review demonstrating significant benefits of VTV 
compared to PLV (34), questions persist about the optimal use of this mode 
in infants, as the majority of RCTs to date have focussed on preterm infants 
with RDS. It is important that results from these studies are not extrapolated 
to term infants or infants with severe BPD. This would necessitate designing 
large, multicentre studies, adequately powered to enable analysis of 
subgroups such as term-born infants or infants with specific pathologies such 
as meconium aspiration syndrome or severe BPD.  
The time is right for an RCT to compare PAV to VTV and such a study is in 
the process of being undertaken by this research group. PAV offers 
opportunities for superior synchronisation. Whether or not resistance 
unloading has a place in clinical practice is yet to be determined conclusively; 
future studies should address this issue.  
The potential of Neurally Adjusted Ventilatory Assist (NAVA) may surpass 
that of PAV. Small crossover (149) and pilot studies (150) have already been 
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carried out studying the effects of NAVA in infants. The scene has been set 
for RCTs assessing NAVA, but further studies may be required to clarify the 
optimal weaning strategy.  
Electrical Impedance Tomography (EIT) is a non-invasive method of 
measuring relative distribution of volume within the lungs and the feasibility of 
using it in ventilated preterm infants has been demonstrated (151). It has 
been shown to be a highly reproducible measurement in animal and human 
studies (152, 153). Along with measures of WOB, respiratory muscle strength 
and asynchrony, EIT could provide additional information on the efficacy of 
ventilation techniques. EIT could be used to determine settings for a 
particular mode in a particular clinical situation (for example, 
bronchopulmonary dysplasia in preterm infants or meconium aspiration 
syndrome in term infants), to optimise distribution of volume within the lungs. 
It would be interesting to study whether better distribution of lung volumes 
assessed by EIT correlated with better oxygenation and CO2 clearance, 
better respiratory muscle strength and reduced work of breathing. If so, EIT 
could be used as a proxy non-invasive technique within the setting of RCTs 
comparing different modes of ventilation; its main advantage is that 
information could be captured continuously, in contrast to the intermittent 
invasive recordings performed as part of traditional physiological 
measurements.  
Avoidance of invasive modes of ventilation is gaining momentum (154-156) 
in preterm infants. There is a lack of evidence relating to the use of non-
invasive modes in infants born at term and future studies should explore the 
use of CPAP and biphasic CPAP in this group of patients. Despite these 
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modalities being used on an increasingly regular basis in paediatric practice, 
there is a reluctance to use them in term born infants because of a belief, 
which seems more based in anecdote as opposed to evidence, that term 
infants will ‘fight’ CPAP and be at a higher risk of air leaks. The reasoning 
behind this school of thought may be related to term born infants’ greater 
respiratory drive and ability to generate higher transpulmonary pressures 
which increase the risk of air leak. Studies of non-invasive modes in term 
born infants may conclusively establish the safety of CPAP in this population. 
High-flow nasal cannula therapy is starting to be used in term born infants 
admitted to NICU with mild-moderate respiratory distress. There is no 
evidence to support this practice, so studies in this area should be planned in 
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